syndrome	score	normalized_score
DRAVET SYNDROME	2.7202118999999993	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	55.90523480909706
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	1.34778266	49.54697316043652
MYOCLONIC-ASTASTIC EPILEPSY	1.2207122540000002	44.87563097566041
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	43.8823901917347
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	42.35391588427359
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	1.0909091	40.10382794075713
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	1.066415079	39.203382611479654
HYPERLIPOPROTEINEMIA, TYPE I	1.0232558	37.6167680172269
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0232558	37.6167680172269
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.00270409	36.86124930193858
EHLERS-DANLOS SYNDROME, TYPE I	1.00163132	36.821812300725554
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	36.781745532397686
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	36.781745532397686
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	36.76184197267868
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	36.76184197267868
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.0	36.76184197267868
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	34.351763551949766
LAFORA DISEASE	0.8230060600000001	30.25521872027691
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.329304051643927
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.7659786500000001	28.158786085745756
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	27.519141578639523
EARLY MYOCLONIC ENCEPHALOPATHY	0.7307892039999999	26.865157232787638
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7054474139999999	25.93354635350283
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.7029457100000001	25.84157910639242
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.6271692	23.05589502053131
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.6271692	23.05589502053131
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.6198357	22.78630205242467
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.610695934	22.45030741906541
BILATERAL POLYMICROGYRIA	0.606829964	22.308187240854295
ROLANDIC EPILEPSY	0.5906213	21.71232689629805
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5564516399999999	20.456187255117882
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	19.660604381592485
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.37448328933493
MEDULLOBLASTOMA	0.519029304	19.080473252837404
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.518324164	19.054551007588792
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.63980706797144
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.38092098633934
INHALATIONAL ANTHRAX	0.5	18.38092098633934
PAROXYSMAL HEMICRANIA	0.5	18.38092098633934
CREST SYNDROME	0.5	18.38092098633934
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.38092098633934
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.48410971	17.796764656459306
SPINOCEREBELLAR ATAXIA TYPE 10	0.44863226	16.492548245965697
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43961312	16.16098804655623
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.434614804	15.977240743634718
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.429205304	15.778377559483515
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.42691399999999996	15.694145003924145
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.41931105	15.414646557497969
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.39879430399999993	14.66041318325238
GLOMUVENOUS MALFORMATION	0.392857	14.442146951860629
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.385930204	14.187505171931647
PLACENTAL INSUFFICIENCY	0.3768113	13.85227746411962
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.36507529	13.420840119109842
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.40189380099396
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.143007719361865
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.143007719361865
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.039458433366905
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34912821	12.834596084224176
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.348076944	12.795949609660928
COG4-CDG	0.344567104	12.666921426231543
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.512821151911
SPINOCEREBELLAR ATAXIA TYPE 42	0.33846121	12.442457515901614
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33496432	12.313905398325772
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.253935070278903
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.253935070278903
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.333333	12.253935070278903
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.253935070278903
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.31587301	11.612073677054353
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.313329614	11.51857375522841
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.304116984	11.179900507015649
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.29943673000000004	11.007845749075654
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.29653465000000007	10.901159942723584
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.2630543	9.67036060683361
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.397427972431123
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25512821	9.378982938792383
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.254187719	9.344408757273653
PALLISTER-HALL SYNDROME	0.250545554	9.210516063105233
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	9.210516063105233
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.250168973	9.19667225189332
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.19046049316967
HYPERPARATHYROIDISM 2	0.25	9.19046049316967
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	9.19046049316967
HYPEREKPLEXIA 1; HKPX1	0.25	9.19046049316967
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.19046049316967
SEVERE HEMOPHILIA A	0.25	9.19046049316967
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	9.19046049316967
DYSTONIA 6, TORSION	0.25	9.19046049316967
CONGENITAL FACTOR II DEFICIENCY	0.25	9.19046049316967
HEMOPHILIA B	0.25	9.19046049316967
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	9.19046049316967
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	9.19046049316967
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.24651401	9.062309079671332
TRICHOTHIODYSTROPHY	0.244342084	8.98246507928298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	8.934787543573355
LENNOX-GASTAUT SYNDROME	0.23257131	8.549749745598865
UNILATERAL POLYMICROGYRIA	0.23245136	8.545340162654243
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.227471804	8.36228251188814
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.305571709321619
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.22536641400000001	8.28488449741728
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.22463191000000005	8.257882777440981
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.22332433	8.209813728114344
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.222851819	8.192443353401993
CONGENITAL MYASTHENIC SYNDROME	0.222851819	8.192443353401993
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.140424648535655
CLEFT VELUM	0.2208333	8.118238876905142
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.21415611399999995	7.872773220350959
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.20952369999999998	7.702477148930935
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.20952369999999998	7.702477148930935
AUTOIMMUNE HYPOPARATHYROIDISM	0.20952369999999998	7.702477148930935
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.20952369999999998	7.702477148930935
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.20952369999999998	7.702477148930935
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.20657895	7.594222714781891
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.20613550300000003	7.577920786244634
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.543099859242584
ADNP SYNDROME	0.204591729	7.5211688104151015
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.202661814	7.4502215801644
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	7.432112182142872
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	7.432112182142872
ROMANO-WARD SYNDROME	0.200541419	7.3722719542547415
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.352368394535737
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.352368394535737
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.352368394535737
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.2	7.352368394535737
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.352368394535737
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.186788954	6.866706009189947
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.66440044615642
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.66440044615642
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.17511509999999997	6.437553633229823
WRINKLY SKIN SYNDROME	0.16843297399999999	6.191906373176296
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.16341620399999998	6.007480667223021
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.16114469999999997	5.923975996134714
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15970406399999998	5.871015563162561
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.863723337141494
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.863723337141494
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.157487054	5.789514191890714
DE BARSY SYNDROME	0.15693867399999997	5.7693547329897354
EHLERS-DANLOS SYNDROME, TYPE VI	0.15603914	5.736286206232685
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15281849	5.617889179883377
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.15220579	5.595365199306718
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.45741675492266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14829852	5.451726757022128
FREE SIALIC ACID STORAGE DISEASE	0.146648063	5.391052917605427
PHACE SYNDROME	0.145170963	5.336752000827583
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.145170963	5.336752000827583
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.331430246298092
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.143881114	5.289334775720967
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	5.271590018409963
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.14339841899999997	5.271590018409963
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.251686458690958
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	5.251686458690958
GANGLIONEUROMA	0.14285699999999998	5.251686458690958
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	5.251686458690958
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	5.251686458690958
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.251686458690958
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	5.251686458690958
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.251686458690958
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.251686458690958
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.251686458690958
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	5.251686458690958
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	5.251686458690958
SCHINZEL-GIEDION SYNDROME	0.14162570000000002	5.20642160267
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.057205433150264
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.13659030000000003	5.021311023600774
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.870161034145908
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.1316284	4.838902439916539
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.128791063	4.734596705499305
NIEMANN-PICK DISEASE, TYPE C2	0.128791063	4.734596705499305
LATHOSTEROLOSIS	0.128399729	4.720210546832767
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12752317999999999	4.687986991013458
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.127018519	4.669434723081684
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.12649583	4.650219712662827
NON-DISTAL MONOSOMY 20Q	0.12376703900000001	4.5499043291443595
SPINOCEREBELLAR ATAXIA 13	0.1212173	4.456171226954783
SPINOCEREBELLAR ATAXIA TYPE 37	0.1211226	4.452689880519971
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.445088046265808
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.12036106000000002	4.424694267384098
CEREBELLAR ATAXIA, CAYMAN TYPE	0.119758264	4.402534376090334
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.11974119	4.401906704400493
PAPILLARY TUMOR OF THE PINEAL REGION	0.1185898	4.35957948717157
PINEOCYTOMA	0.1185898	4.35957948717157
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.343531105058397
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.11270772899999999	4.143343722597494
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.11195645000000001	4.115725322722103
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.1114059	4.095486090624044
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.1070381	3.934917717255778
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.924652487550696
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.10633090400000002	3.9089198896600683
AICARDI SYNDROME; AIC	0.10491369	3.8568204925506
EPISODIC ATAXIA, TYPE 1; EA1	0.10451840000000001	3.84228890403722
NOONAN SYNDROME 7; NS7	0.103573389	3.8075485589927767
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.1029573	3.784899992533671
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.1028139	3.7796283443947885
8Q24.3 MICRODELETION SYNDROME	0.10236869300000001	3.763261715015659
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.102084794	3.752825064841457
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10179004400000001	3.74198951192001
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.1015267	3.7323085014075565
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.10108697300000001	3.7161433269224373
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.10054555400000001	3.6962397672034313
THYROCEREBRORENAL SYNDROME	0.100541419	3.696087756986874
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.10025636	3.6856084630759844
PSEUDOAMINOPTERIN SYNDROME	0.09993327400000002	3.6737312266004
17Q23.1Q23.2 MICRODELETION SYNDROME	0.09951041	3.658185967056464
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.099121734	3.6438975213658917
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.099026013	3.640378641090425
CONGENITAL ANALBUMINEMIA	0.0989922	3.6391356129278027
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.637698371954038
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.6171393118308184
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.6171393118308184
PRADER-WILLI SYNDROME	0.09829781900000001	3.613608888336972
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.607139943766882
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.607139943766882
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.607139943766882
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.607139943766882
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.607139943766882
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.09775640000000001	3.5937053286179665
ALSTROM SYNDROME; ALMS	0.096727054	3.5558646736307575
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.09601120399999999	3.5295487090546147
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.09532895400000001	3.5044679423687555
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09515970300000001	3.498245963853038
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.09468210400000002	3.4806885448887286
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.09450785	3.474282646877621
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.09446700000000001	3.472780925633037
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.09436514400000001	3.469036511457068
MARINESCO-SJÖGREN SYNDROME	0.094158744	3.461448867273907
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0930783	3.4217297556855786
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.092920609	3.4159327440630647
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.09290085000000001	3.4152063668275265
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.09213609	3.3870923805605004
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.09184856	3.376522248138096
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.09145051900000001	3.3618895277974494
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.09145051900000001	3.3618895277974494
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.091414554	3.3605673881509013
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.09137276000000001	3.359030963727496
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.091167254	3.351476184631059
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	3.341985968078444
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	3.341985968078444
CORNEODERMATOOSSEOUS SYNDROME	0.0909091	3.341985968078444
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	3.341985968078444
RARE CIRCULATORY SYSTEM DISEASE	0.0909091	3.341985968078444
KUFOR-RAKEB SYNDROME	0.0909091	3.341985968078444
TRISOMY 18P	0.0909091	3.341985968078444
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0909091	3.341985968078444
SPINOCEREBELLAR ATAXIA TYPE 12	0.0909091	3.341985968078444
SAGLIKER SYNDROME	0.0909091	3.341985968078444
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.09025541000000001	3.3179551195993238
AICARDI SYNDROME	0.09017920999999998	3.3151538672410044
SLC35A2-CDG	0.089845904	3.3029009247404595
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.089369319	3.28538078228391
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08915431	3.277476655403207
AMISH INFANTILE EPILEPSY SYNDROME	0.08873365	3.2620124189589794
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.08825747	3.2445071650484296
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.08662846	3.1846217568565165
WILLIAMS SYNDROME	0.08443729000000001	3.1040703115812427
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.08428160000000001	3.098346860404516
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.08396535000000001	3.086720927880656
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.08331235399999999	3.0627155921198645
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.08226293900000001	3.024137163726106
DERMATOMYOSITIS	0.08219867	3.021774516904364
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.08142934399999999	2.9934926760668903
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.081110819	2.9817831103525436
DDOST-CDG	0.08103594900000001	2.9790307512440495
TRISOMY 8P	0.08103594900000001	2.9790307512440495
BECKWITH-WIEDEMANN SYNDROME	0.08097168	2.976668104422307
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.08035600999999999	2.9540349411749873
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08022400400000002	2.949182157463543
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.07978141000000001	2.9329115867774873
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.079545804	2.9242502762376716
HSD10 DISEASE	0.07948717300000001	2.922094892680972
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.07937742900000001	2.9180605010955225
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.07920906900000001	2.9118712773810023
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.07896718300000001	2.9029791024735987
ETHYLMALONIC ENCEPHALOPATHY	0.078941619	2.902039322745409
NEUROFIBROMATOSIS TYPE 1	0.078941619	2.902039322745409
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.078421629	2.882923532538036
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.07837885	2.8813508977002864
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.07788021	2.86301997281903
PEDIATRIC-ONSET GRAVES DISEASE	0.07746865400000001	2.8478904161841228
N SYNDROME	0.07746865400000001	2.8478904161841228
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.8478904161841228
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.8478904161841228
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.82783484624856
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.82783484624856
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	2.82783484624856
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.82783484624856
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.82783484624856
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.82783484624856
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.82783484624856
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.82783484624856
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.82783484624856
DERMOODONTODYSPLASIA	0.07692310000000001	2.82783484624856
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.07647713	2.811440167584004
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.805263075277335
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.076018599	2.7945837234224298
GRISCELLI SYNDROME	0.075219663	2.7652133644441457
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.07501014	2.757510913028504
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.074483139	2.7381373855470605
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.7250726312902316
NIEMANN-PICK DISEASE TYPE B	0.0741225	2.724879631619875
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0735978	2.705590693136811
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07305992000000001	2.685817233576547
KENNEDY DISEASE	0.07265559	2.6709533180117337
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07265559	2.6709533180117337
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.6658060351842456
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.072369839	2.6604485849061987
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0723447	2.6595244289608475
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.072287404	2.6574181224631808
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.07197415400000001	2.6459024754652396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.6459024754652396
3MC SYNDROME 2	0.07197415400000001	2.6459024754652396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6459024754652396
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.07197415400000001	2.6459024754652396
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.07197415400000001	2.6459024754652396
GM2 GANGLIOSIDOSIS, AB VARIANT	0.07197001900000001	2.6457504652486823
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.071920273	2.6439217106579096
3MC SYNDROME 3	0.07142860000000001	2.6258469055296767
3MC SYNDROME 1	0.07142860000000001	2.6258469055296767
STIFF SKIN SYNDROME	0.07142860000000001	2.6258469055296767
HYPOALPHALIPOPROTEINEMIA	0.07142860000000001	2.6258469055296767
3MC SYNDROME	0.07142860000000001	2.6258469055296767
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07142860000000001	2.6258469055296767
ADULT-ONSET STILL DISEASE	0.07142860000000001	2.6258469055296767
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.6258469055296767
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07142860000000001	2.6258469055296767
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.07142860000000001	2.6258469055296767
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07142860000000001	2.6258469055296767
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.6258469055296767
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	2.6258469055296767
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.07141057399999999	2.6251842365662763
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.07123096	2.6185812950821963
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.071001303	2.6101386807402767
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.06878306	2.528591982117276
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5253069439185976
PONTINE TEGMENTAL CAP DYSPLASIA	0.06865862299999999	2.5240174487877214
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0683405	2.5123226613338474
SPINOCEREBELLAR ATAXIA TYPE 26	0.0683405	2.5123226613338474
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06789368999999999	2.4958971027220347
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.06789368999999999	2.4958971027220347
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.06773266400000001	2.4899774903565426
CHRISTIANSON SYNDROME	0.0677057	2.488986244049591
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067378873	2.4769714815231865
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.4708462601755405
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.4706942499589832
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.066876204	2.4584924431806217
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.066856414	2.457764926327983
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.4507906902399776
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.4507906902399776
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.4507906902399776
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.4507906902399776
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.4507906902399776
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.4507906902399776
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.437012351868618
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.06565660000000001	2.4136575536633753
SPINOCEREBELLAR ATAXIA 5; SCA5	0.064820114	2.382906787519017
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.3827114350907745
WILLIAMS-BEUREN SYNDROME; WBS	0.06428032	2.363062965793217
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.063748	2.3434939020743206
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0627413	2.306485755760425
FABRY DISEASE	0.062258719000000004	2.2887451892994077
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.06216575	2.2853274776130497
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.062061939999999996	2.2815112307978658
SPINOCEREBELLAR ATAXIA 1	0.06197244	2.278221045941311
WHITE-SUTTON SYNDROME; WHSUS	0.061841784000000004	2.273417890716529
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.061511063	2.261259977577483
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.061387573	2.2567202577122765
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06109523	2.2459731905444578
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.232168016028458
GIANT CELL ARTERITIS	0.0603006	2.2167611280577084
SPINOCEREBELLAR ATAXIA TYPE 34	0.060291899999999995	2.2164413000325456
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.060277554000000004	2.2159139146476057
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.2070302684875402
DYSTONIA-APHONIA SYNDROME	0.059910473	2.2024193409344326
LYSINURIC PROTEIN INTOLERANCE	0.059889200000000004	2.201637306270148
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.059871714	2.200994488701414
MACHADO-JOSEPH DISEASE TYPE 2	0.0597517	2.1965825529989047
MACHADO-JOSEPH DISEASE TYPE 1	0.0597517	2.1965825529989047
MACHADO-JOSEPH DISEASE TYPE 3	0.0597517	2.1965825529989047
15Q OVERGROWTH SYNDROME	0.059708969	2.1950116827295703
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.1911594460710955
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.1911594460710955
EMANUEL SYNDROME	0.059459202999999995	2.185829824507422
7Q11.23 MICRODUPLICATION SYNDROME	0.059259468999999995	2.178487234762851
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.059210599999999995	2.176690720307488
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.1736185331738316
GITELMAN SYNDROME	0.059127030000000004	2.1736185331738316
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.058852919000000004	2.1635417079088586
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0588235	2.1624602112798645
MYASTHENIA GRAVIS; MG	0.0588235	2.1624602112798645
CLEFT LIP AND ALVEOLUS	0.0588235	2.1624602112798645
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.0588235	2.1624602112798645
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0588235	2.1624602112798645
OROMANDIBULAR DYSTONIA	0.0588235	2.1624602112798645
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0588235	2.1624602112798645
CITRULLINEMIA TYPE II	0.058806973	2.161852648317582
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.058323464	2.144077966867214
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.05812102399999999	2.1366358995782644
ANGELMAN SYNDROME	0.057780872999999996	2.1241313222694163
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.124022396931651
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.05772	2.1218935186630135
DYSBETALIPOPROTEINEMIA	0.05772	2.1218935186630135
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.05772	2.1218935186630135
NIEMANN-PICK DISEASE, TYPE B	0.05772	2.1218935186630135
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.05772	2.1218935186630135
FISH-EYE DISEASE	0.05772	2.1218935186630135
ATHEROSCLEROSIS SUSCEPTIBILITY	0.05772	2.1218935186630135
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.05772	2.1218935186630135
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.057486688999999994	2.1133165765505257
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.1075343431884854
DOORS SYNDROME	0.057079424	2.098344764979523
MEIER-GORLIN SYNDROME 1; MGORS1	0.056680180000000004	2.083667820142983
EPISODIC ATAXIA, TYPE 6	0.056292618999999995	2.069420363906209
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.056224779	2.066926440546783
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.056031329	2.059814862217168
WILSON DISEASE	0.056005400000000004	2.058861664416659
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.055861654	2.053577296680454
SPINOCEREBELLAR ATAXIA 26	0.055651110000000004	2.045837311424158
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.042326187897348
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.042326187897348
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.042326187897348
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.042326187897348
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.042326187897348
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.042326187897348
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.042326187897348
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.042326187897348
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.042326187897348
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.042326187897348
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.055135553000000004	2.02688448646225
TEMPLE SYNDROME	0.054048580000000006	1.986925356807682
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.05385859	1.9799409744512921
XQ12-Q13.3 DUPLICATION SYNDROME	0.053784269999999995	1.9772088343558827
EPISODIC ATAXIA, TYPE 2	0.053571499999999994	1.9693870172393557
ERYTHERMALGIA, PRIMARY	0.05307093	1.9509851420030921
SPINOCEREBELLAR ATAXIA 18	0.053010949999999994	1.948780166721571
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.05294409299999999	1.9463223802528031
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.052718293	1.9380215563353727
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9348345619692353
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	1.9348345619692353
KNIEST-LIKE DYSPLASIA, LETHAL	0.0526316	1.9348345619692353
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9348345619692353
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	1.9348345619692353
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9348345619692353
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9348345619692353
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.05161315	1.8973944640121605
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.05161315	1.8973944640121605
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.051563309	1.8955622170464006
CHROMOSOME 17Q12 DELETION SYNDROME	0.05138561999999999	1.889030042108117
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.05137011	1.8884598659391207
16P13.2 MICRODELETION SYNDROME	0.051332073	1.8870615557560062
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.8815122086628624
ADRENOLEUKODYSTROPHY	0.051064319000000004	1.8772184255204536
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.050545554	1.8581476685694969
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.050541419000000004	1.85799565835294
NEUROLEPTIC MALIGNANT SYNDROME	0.05	1.8380920986339342
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.05	1.8380920986339342
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.049932963	1.8356276950336117
XP22.13P22.2 DUPLICATION SYNDROME	0.049886718999999996	1.8339276804134268
ALG13-CDG	0.049802	1.8308132539233437
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04975873399999999	1.8292227160685535
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.04962755399999999	1.8244002976385774
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.049585960000000005	1.8228712255835662
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.049556132999999995	1.8217747301230471
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.049335500000000004	1.8136638546430894
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.049114434	1.805537061285557
COG5-CDG	0.049108719	1.8053269673586831
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8041555512642238
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	1.8040546767698502
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.049064204	1.8036905139632693
LISSENCEPHALY, X-LINKED, 2	0.048938699	1.7990767189864882
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04893246	1.7988473618544207
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.04884065	1.7954722571429091
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.048708949999999994	1.790630722555107
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.048705973	1.7905212825515544
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.048691114	1.7899750383416826
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.048388319	1.7788437364015652
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.048388319	1.7788437364015652
DISTAL 17P13.1 MICRODELETION SYNDROME	0.04820264999999999	1.77201820196434
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.048160419	1.7704657126159917
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.048160419	1.7704657126159917
HAMAMY SYNDROME; HMMS	0.04811831	1.7689177082123642
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.048022503	1.765395666418488
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.047892103	1.7606019222252505
SPINOCEREBELLAR ATAXIA 2; SCA2	0.04788794	1.760448882677118
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.047643703999999995	1.751470317441079
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.047619	1.7505621528969864
APOLIPOPROTEIN A-I DEFICIENCY	0.047619	1.7505621528969864
HYPERLIPOPROTEINEMIA, TYPE V	0.047619	1.7505621528969864
TANGIER DISEASE; TGD	0.047619	1.7505621528969864
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.047619	1.7505621528969864
FISH-EYE DISEASE	0.047619	1.7505621528969864
SPINOCEREBELLAR ATAXIA 42	0.047619	1.7505621528969864
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.047619	1.7505621528969864
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.047619	1.7505621528969864
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.047619	1.7505621528969864
TURNPENNY-FRY SYNDROME; TPFS	0.04749979399999999	1.7461799207627908
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04747941	1.74543056737602
MENTAL RETARDATION, X-LINKED 98; MRX98	0.04745448299999999	1.7445142049411666
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0474338	1.743753859763646
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.04731445000000001	1.7393663339242071
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.04713263299999999	1.73268240610226
SALT-AND-PEPPER SYNDROME	0.047118604	1.7321666742212256
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.046734039000000005	1.7180293564630027
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7170632920178026
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.04650659	1.7096679122681586
MALAN OVERGROWTH SYNDROME	0.046256699	1.700481458815764
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.045832329000000005	1.6848808359378187
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.6827753014388331
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04571528	1.6805778990967584
HALLERMANN-STREIFF SYNDROME; HSS	0.04550375	1.6728016666642778
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.045467169	1.671456881723075
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.045179024	1.6608641407678575
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.045062889999999994	1.6565948410122024
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04504809	1.6560507657510066
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.6533109056687831
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6515444991619956
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.044913110000000006	1.651088652321535
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.6338583769889403
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.044377319	1.631391988249151
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.044202130000000006	1.6249517179158
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04407925	1.6204344227741967
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	1.6183979637762784
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.6182459535597216
LASSA FEVER	0.044019719000000006	1.6182459535597216
KEUTEL SYNDROME; KTLS	0.044019719000000006	1.6182459535597216
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6182459535597216
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044019003	1.6182196320808688
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.04398066299999999	1.616810183059636
CHROMOSOME 1P36 DELETION SYNDROME	0.043823392999999995	1.6110286481725928
QAZI-MARKOUIZOS SYNDROME	0.043812238999999996	1.6106186065872299
PGM3-CDG	0.043685219	1.6059491174198601
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.043631803999999996	1.6039854836308893
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.5983423938407157
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.5983423938407157
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.5983423938407157
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.5983423938407157
YELLOW FEVER	0.043478300000000004	1.5983423938407157
ASHERMAN SYNDROME	0.043478300000000004	1.5983423938407157
HYDATIDIFORM MOLE	0.043478300000000004	1.5983423938407157
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.5983423938407157
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.5983423938407157
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.5983423938407157
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.5983423938407157
WERNER SYNDROME	0.043478300000000004	1.5983423938407157
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.04343510899999999	1.5967546131240733
49,XXXYY SYNDROME	0.04329801999999999	1.5917149689698806
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.043297969000000006	1.5917130941159405
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.5899038600632551
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.043195623999999995	1.5879507033992462
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.04316571	1.586851009658476
EPISODIC ATAXIA, TYPE 8	0.043143799999999996	1.5860455577008543
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.5852334886116783
PEHO SYNDROME	0.043055784	1.5828099274177874
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.042985614	1.5802303489665641
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.04289368999999999	1.5768510534050675
49,XYYYY SYNDROME	0.04289368999999999	1.5768510534050675
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5718095343969347
HARTNUP DISORDER	0.04275367299999999	1.571703770577579
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0423591	1.5571985403048934
COG2-CDG	0.04221225399999999	1.5518002108585731
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5518002108585731
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.042208118999999995	1.5516482006420163
EPISODIC ATAXIA TYPE 3	0.042208118999999995	1.5516482006420163
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.042208118999999995	1.5516482006420163
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.5516482006420163
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0422078	1.5516364736144272
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.0422078	1.5516364736144272
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0422078	1.5516364736144272
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0422078	1.5516364736144272
19P13.3 MICRODUPLICATION SYNDROME	0.04217420399999999	1.5504014227715128
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04216521	1.550070786764811
3P25.3 MICRODELETION SYNDROME	0.04201393	1.5445094553111838
ZELLWEGER SYNDROME	0.04193561900000001	1.5416305987044618
GABRIELE-DE VRIES SYNDROME	0.04189021	1.5399612802223241
EPISODIC ATAXIA, TYPE 7; EA7	0.041666699999999994	1.5317446409230107
EPISODIC ATAXIA, TYPE 5	0.041666699999999994	1.5317446409230107
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.041666699999999994	1.5317446409230107
EPISODIC ATAXIA, TYPE 3	0.041666699999999994	1.5317446409230107
HISTIDINEMIA	0.041666699999999994	1.5317446409230107
EPISODIC ATAXIA TYPE 7	0.041666699999999994	1.5317446409230107
EPISODIC ATAXIA, TYPE 4	0.041666699999999994	1.5317446409230107
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5317446409230107
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.04152505	1.526537326007581
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.041469549999999994	1.524497043778097
SPINOCEREBELLAR ATAXIA TYPE 6	0.04142321	1.5227935000210833
SHPRINTZEN OMPHALOCELE SYNDROME	0.041319810000000005	1.5189923255611086
3Q13 MICRODELETION SYNDROME	0.04131981	1.5189923255611082
PITT-HOPKINS SYNDROME	0.041309859	1.5186265084716382
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.041085580000000003	1.5103815993158478
300270 ADRENOMYODYSTROPHY	0.040936193999999995	1.504889894790917
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.040697983	1.4961328196527635
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.04056659399999999	1.4913027179978147
ACROCEPHALOPOLYDACTYLY	0.04009282	1.4738859130790514
245800 LAURENCE-MOON SYNDROME	0.039938600000000005	1.4682165018100248
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.03988436	1.4662225395014268
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.03988436	1.4662225395014268
DEND SYNDROME	0.039841769	1.4646568158899684
16P13.11 MICRODELETION SYNDROME	0.039751754	1.4613476986847977
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.03974096	1.4609508913625444
VELOCARDIOFACIAL SYNDROME	0.03968849	1.4590219975142382
MACHADO-JOSEPH DISEASE; MJD	0.0395146	1.4526294808136089
MOEBIUS SYNDROME; MBS	0.03935279999999999	1.4466814147824294
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4437147341352348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.039119583	1.4381079282830873
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.039009459999999996	1.43405960395953
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.039002919000000004	1.433819144751187
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.038970473000000005	1.4326263700265416
LISSENCEPHALY 2; LIS2	0.038809543999999994	1.42671032355972
9Q31.1Q31.3 MICRODELETION SYNDROME	0.038709709999999994	1.4230402418282195
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.038709709999999994	1.4230402418282195
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.038599784	1.418999159587531
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.416113943182147
MYOCLONUS AND ATAXIA	0.0385141	1.415849257919944
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0384747	1.4144008413462206
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	1.4139155850321812
WIDOW'S PEAK SYNDROME	0.0384615	1.4139155850321812
BAZEX SYNDROME; BZX	0.0384615	1.4139155850321812
MAL DE MELEDA	0.0384615	1.4139155850321812
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.4139155850321812
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.4139155850321812
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4139155850321812
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0384615	1.4139155850321812
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4139155850321812
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4139155850321812
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4139155850321812
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4139155850321812
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4139155850321812
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.4139155850321812
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	1.4139155850321812
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4139155850321812
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4139155850321812
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0384615	1.4139155850321812
MUCOLIPIDOSIS III GAMMA	0.0384615	1.4139155850321812
MYCETOMA	0.0384615	1.4139155850321812
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.4139155850321812
CYCLIC NEUTROPENIA	0.0384615	1.4139155850321812
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	1.4139155850321812
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4139155850321812
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.4139155850321812
LIP, HAMARTOMATOUS	0.0384615	1.4139155850321812
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4139155850321812
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4139155850321812
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4139155850321812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.038424919	1.4125708000909787
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.038424919	1.4125708000909787
CANAVAN DISEASE	0.03826399	1.4066547536241572
CEREBROFACIOARTICULAR SYNDROME	0.038136774	1.401978059135761
ALPERS-HUTTENLOCHER SYNDROME	0.038069694	1.3995120747762337
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.037927729	1.3942931798805824
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.392658417529899
YOU-HOOVER-FONG SYNDROME; YHFS	0.037736954	1.387279939478245
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0376773	1.3850869485572064
16P12.1P12.3 TRIPLICATION SYNDROME	0.03749473	1.3783753390682545
PITT-HOPKINS-LIKE SYNDROME	0.037360629	1.3734455392978764
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.037254763999999996	1.3695537468974386
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.037106214	1.3640927752723973
MCLEOD SYNDROME; MCLDS	0.037037	1.3615483411421003
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3615483411421003
DISTAL 16P11.2 MICRODELETION SYNDROME	0.037034723	1.3614646344279284
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.3528825824194068
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.036784003999999995	1.3522477421703805
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.345020180229342
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03630668	1.3347004327126135
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715000000001	1.3343500923586142
SLC39A8-CDG	0.036255719000000006	1.3328270124838442
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.036255719000000006	1.3328270124838442
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.3328270124838442
OROFACIODIGITAL SYNDROME TYPE 14	0.036255343999999995	1.3328132267931039
PMM2-CDG	0.036134142999999994	1.3283576547841733
THUMBS, CONGENITAL CLASPED	0.0361093	1.327444380344046
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	1.3251166205103364
OCULODENTODIGITAL DYSPLASIA	0.035907939	1.3200419790825857
SPINOCEREBELLAR ATAXIA TYPE 13	0.03580728300000001	1.3163416791169842
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3111570462580509
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3111570462580509
SPINOCEREBELLAR ATAXIA TYPE 23	0.03566016	1.3109331666404374
SPINOCEREBELLAR ATAXIA TYPE 35	0.03566016	1.3109331666404374
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035569773	1.3076103740300529
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.03529719299999999	1.2975898311451397
INHERITED CREUTZFELDT-JAKOB DISEASE	0.035118329	1.2910144610425387
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.035028354	1.287706814311047
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.034833333999999994	1.280537519889535
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.2800491755807706
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.03475615	1.2777000938787162
SPINOCEREBELLAR ATAXIA TYPE 1	0.03461275	1.2724284457398338
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.03461275	1.2724284457398338
SPINOCEREBELLAR ATAXIA 12	0.03461275	1.2724284457398338
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	1.2676512443754844
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.034434974	1.2658930725212991
MEIER-GORLIN SYNDROME 5; MGORS5	0.034427299999999994	1.2656109621460006
ISOTRETINOIN-LIKE SYNDROME	0.034427299999999994	1.2656109621460006
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.034313750000000004	1.2614366549900031
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.034313750000000004	1.2614366549900031
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.034299292999999995	1.2609051890406038
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.034276619	1.2600716510357155
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.034147369	1.2553201829607468
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03403064399999999	1.2510291569564858
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.034005933999999995	1.250120771841341
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.033889419999999996	1.2458375025857362
9P13 MICRODELETION SYNDROME	0.033889419999999996	1.2458375025857362
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033889419999999996	1.2458375025857362
HOLMES-GANG SYNDROME	0.03375787399999999	1.241001629321598
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.033755623	1.2409188784153178
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033485089999999995	1.230973587020923
DENT DISEASE	0.033485089999999995	1.230973587020923
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.033485089999999995	1.230973587020923
RAMOS-ARROYO SYNDROME	0.03346038	1.2300652019057783
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.033369719	1.2267323365506932
GLYCOGEN STORAGE DISEASE VI	0.0333568	1.2262574103142483
EPILEPSY, PYRIDOXINE-DEPENDENT	0.033356234	1.2262366031116916
SPINOCEREBELLAR ATAXIA 34; SCA34	0.03330541	1.2243682192552723
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.033283113	1.2235485404648077
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0332372	1.221860694014316
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	1.2125242890085144
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.032830709	1.2069173361089998
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2059227444744287
HYDROXYKYNURENINURIA	0.032803653999999995	1.2059227444744287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2059227444744287
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2059227444744287
TUBEROUS SCLEROSIS-1	0.032799519	1.2057707342578718
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2057707342578718
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2057707342578718
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.03273801	1.2035095501199744
SPINOCEREBELLAR ATAXIA TYPE 36	0.03271165	1.2025405079655747
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.03265264	1.2003711916707667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.032487842999999995	1.1943129503991952
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.1858671745388663
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1858671745388663
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.1858671745388663
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.1858671745388663
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.1858671745388663
WEST SYNDROME	0.0322581	1.1858671745388663
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.1858671745388663
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.1858671745388663
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.1858671745388663
SECKEL SYNDROME 2; SCKL2	0.0322581	1.1858671745388663
DESMOID TUMOR	0.0322581	1.1858671745388663
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.1858671745388663
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.1858671745388663
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.1858671745388663
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.1858671745388663
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.1858671745388663
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.1858671745388663
SECKEL SYNDROME	0.0322581	1.1858671745388663
THROMBOCYTOPENIA 1	0.0322581	1.1858671745388663
COG1-CDG	0.0322581	1.1858671745388663
INFANTILE MYOFIBROMATOSIS	0.0322581	1.1858671745388663
MILD CANAVAN DISEASE	0.0322581	1.1858671745388663
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.1858671745388663
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.03195515	1.1747301745132432
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.031842643999999996	1.1705942467202648
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.031725763	1.1662974858686563
15Q13.3 MICRODELETION SYNDROME	0.031723083	1.1661989641321695
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.031529989999999994	1.1591005097801388
NARP SYNDROME	0.031389972999999995	1.1539532269526505
SPINOCEREBELLAR ATAXIA 27; SCA27	0.03126091	1.1492086333421307
SPINOCEREBELLAR ATAXIA 15	0.03126091	1.1492086333421307
SPINOCEREBELLAR ATAXIA TYPE 27	0.03126091	1.1492086333421307
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1479587307150594
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.03111751	1.1439369852032486
HUNTINGTON DISEASE-LIKE 1	0.03096915	1.138482998328182
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.1338976570170876
HUNTINGTON DISEASE-LIKE 3	0.030844418999999998	1.1338976570170876
2Q24 MICRODELETION SYNDROME	0.030676129	1.1277110066315057
8P INVERTED DUPLICATION/DELETION SYNDROME	0.030676129	1.1277110066315057
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.030546779	1.1229558623723397
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.030439623	1.1190166104339154
NORMAL PRESSURE HYDROCEPHALUS	0.030302999999999997	1.113994097298082
CARIBBEAN PARKINSONISM	0.030302999999999997	1.113994097298082
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.113994097298082
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.113994097298082
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03024371	1.111814487687522
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.030213499999999997	1.1107039124415272
GLYCINE ENCEPHALOPATHY	0.030092559999999997	1.1062579352733515
CURRY-JONES SYNDROME	0.029957354	1.1012875136675935
CURRARINO SYNDROME	0.029957354	1.1012875136675935
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.029953219	1.1011355034510366
HUNTINGTON DISEASE-LIKE 1	0.029792479000000004	1.0952264049723484
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.092230094280523
SPINOCEREBELLAR ATAXIA TYPE 3	0.0294487	1.0825884557008227
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	1.0812319437320308
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	1.0812319437320308
AL AMYLOIDOSIS	0.0294118	1.0812319437320308
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.029263249999999998	1.0757709721069895
STICKLER SYNDROME, TYPE II	0.029263249999999998	1.0757709721069895
MENINGIOMA	0.0292549	1.0754640107265174
SPINOCEREBELLAR ATAXIA TYPE 43	0.02908121	1.069078846394283
SPINOCEREBELLAR ATAXIA TYPE 14	0.02908121	1.069078846394283
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.029004790000000003	1.0662695064307308
OSTEOPENIA AND SPARSE HAIR	0.029004790000000003	1.0662695064307308
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0522709646259545
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0522709646259545
SPINOCEREBELLAR ATAXIA TYPE 29	0.028381714	1.0433640849817623
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.028381714	1.0433640849817623
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0412186638842367
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0412186638842367
MENKES DISEASE	0.028319219000000003	1.0410666536676798
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.02783616	1.0233085150461994
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.02783616	1.0233085150461994
SPINOCEREBELLAR ATAXIA TYPE 40	0.02783616	1.0233085150461994
SPINOCEREBELLAR ATAXIA 44; SCA44	0.02783616	1.0233085150461994
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.021163093948674
DIMPLES, FACIAL	0.027777800000000002	1.021163093948674
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.021163093948674
OROFACIAL CLEFT 3	0.027777800000000002	1.021163093948674
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.021163093948674
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.021163093948674
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.021163093948674
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.021163093948674
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.021163093948674
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.021163093948674
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.021163093948674
DWARFISM, LEVI TYPE	0.027777800000000002	1.021163093948674
GANGLIOCYTOMA	0.027777800000000002	1.021163093948674
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.021163093948674
CLEFT CHIN	0.027777800000000002	1.021163093948674
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.021163093948674
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.021163093948674
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.021163093948674
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.021163093948674
NASAL BONES, ABSENCE OF	0.027777800000000002	1.021163093948674
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.021163093948674
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.021163093948674
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.021163093948674
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.021163093948674
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.021163093948674
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.021163093948674
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.021163093948674
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.021163093948674
19P13.13 MICRODELETION SYNDROME	0.027614793	1.0151706563742333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0136178729311494
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.027369249999999998	1.0061440434107358
ACUTE INTERMITTENT PORPHYRIA	0.027368649000000002	1.0061219495437104
TRISOMY 20P	0.02724851	1.0017054186109546
19P13.12 MICRODELETION SYNDROME	0.027201083	0.9999619147317165
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9935623029955867
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9935623029955867
BENIGN OCCIPITAL EPILEPSY	0.027027	0.9935623029955867
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9935623029955867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.026954273	0.9908887245144398
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.026954273	0.9908887245144398
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.026954273	0.9908887245144398
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.02672351	0.9824054515752985
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.026678254000000002	0.980741757654983
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.026678254000000002	0.980741757654983
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.026672583	0.9805332812491558
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.026511973	0.974628961809924
HAREL-YOON SYNDROME; HAYOS	0.026159503999999997	0.9616715521316557
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026148953999999995	0.961283714698844
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.026132700000000002	0.9606861877194203
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.026132700000000002	0.9606861877194203
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.026132700000000002	0.9606861877194203
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.026132700000000002	0.9606861877194203
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.026132700000000002	0.9606861877194203
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026124354	0.9603793733863162
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.025983473	0.9552003283273632
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.025964123	0.9544889866851919
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0258673	0.9509295948598713
GRISCELLI SYNDROME TYPE 1	0.025819873	0.949186090980633
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.025512959999999998	0.9379034037752723
KAGAMI-OGATA SYNDROME	0.025491703	0.9371219573004592
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.025477173000000002	0.9365878077365962
TETRASOMY 5P	0.025445593	0.9354268687670988
CK SYNDROME	0.025445593	0.9354268687670988
GABRIELE-DE VRIES SYNDROME; GADEVS	0.025442054	0.9352967686083575
SPINOCEREBELLAR ATAXIA TYPE 7	0.025422703999999997	0.9345854269661861
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.025024209000000002	0.9199360167492837
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.024935754	0.9166842480175904
COHEN-GIBSON SYNDROME; COGIS	0.024904173999999998	0.9155233090480931
LAMB-SHAFFER SYNDROME	0.024904173999999998	0.9155233090480931
TURNER SYNDROME	0.02488712	0.914896372595091
MOSAIC MONOSOMY X	0.02488712	0.914896372595091
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.02488712	0.914896372595091
MONOSOMY X	0.02488712	0.914896372595091
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.02488188	0.9147037405431541
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.024778583	0.9109063525529024
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9091282190185259
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.024495709	0.900507383266723
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.02448279	0.9000324570302779
SPINOCEREBELLAR ATAXIA TYPE 5	0.0243902	0.8966286780820277
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0243902	0.8966286780820277
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0243902	0.8966286780820277
ORAL SENSIBILITY, DISTURBANCE OF	0.0243902	0.8966286780820277
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.024358619999999997	0.8954677391125303
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.024357674	0.8954329624100242
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.024342773	0.8948851742027895
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.024233029	0.8908507826173396
KAGAMI-OGATA SYNDROME	0.023814273	0.8754565407202286
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.023814273	0.8754565407202286
MEND SYNDROME; MEND	0.023814273	0.8754565407202286
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.023814273	0.8754565407202286
CHROMOSOME 5Q12 DELETION SYNDROME	0.023814273	0.8754565407202286
INFANTILE LIVER FAILURE SYNDROME 1	0.023814273	0.8754565407202286
MEND SYNDROME	0.023814273	0.8754565407202286
GRISCELLI SYNDROME TYPE 2	0.023797219	0.8748296042672266
FAMILIAL MULTIPLE LIPOMATOSIS	0.023797219	0.8748296042672266
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.023794923	0.8747451990780574
SPINOCEREBELLAR ATAXIA 46; SCA46	0.023755360000000003	0.8732907903240923
SPINOCEREBELLAR ATAXIA 23; SCA23	0.023755360000000003	0.8732907903240923
FRIEDREICH ATAXIA	0.023755360000000003	0.8732907903240923
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.023755360000000003	0.8732907903240923
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.023716803999999998	0.8718734007449935
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.02369301	0.8709986894770958
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.023636903	0.8689360928095348
SPINOCEREBELLAR ATAXIA 14	0.02361196	0.8680191421852103
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.02361196	0.8680191421852103
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.023611959999999998	0.86801914218521
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.023551593	0.8657999400708454
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.023468314	0.8627384506332026
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.023444939999999997	0.8618791793389332
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8618721945889585
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.023397373	0.860130528801819
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.023343759999999998	0.8581596161681377
RETT SYNDROME; RTT	0.023325559000000003	0.8574905138823931
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.023272854	0.8555529810012228
CHROMOSOME 15Q25 DELETION SYNDROME	0.023272854	0.8555529810012228
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.023272854	0.8555529810012228
SWEENEY-COX SYNDROME; SWCOS	0.023272854	0.8555529810012228
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023268719	0.8554009707846659
EDINBURGH MALFORMATION SYNDROME	0.023268719	0.8554009707846659
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	0.854926044548221
MICROTRIPLICATION 11Q24.1	0.0232558	0.854926044548221
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.0232558	0.854926044548221
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0232558	0.854926044548221
GLYCOGEN STORAGE DISEASE IA	0.0232558	0.854926044548221
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.0232558	0.854926044548221
PRIMARY LIPODYSTROPHY	0.0232558	0.854926044548221
GLYCOGEN STORAGE DISEASE IB	0.0232558	0.854926044548221
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.0232558	0.854926044548221
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0232558	0.854926044548221
CHOLESTEROL-ESTER TRANSFER PROTEIN DEFICIENCY	0.0232558	0.854926044548221
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0232558	0.854926044548221
AROMATASE DEFICIENCY	0.0232558	0.854926044548221
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	0.854926044548221
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0232558	0.854926044548221
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0232558	0.854926044548221
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.0232558	0.854926044548221
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0232558	0.854926044548221
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.854926044548221
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0232558	0.854926044548221
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.854926044548221
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.023249369	0.8546896291424945
GAUCHER DISEASE	0.02305418	0.8475141219696894
COSTELLO SYNDROME; CSTLO	0.023010173999999998	0.8458963803518396
CHROMOSOME 16Q22 DELETION SYNDROME	0.023010173999999998	0.8458963803518396
RENPENNING SYNDROME 1; RENS1	0.023006039	0.8457443701352827
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.02297406	0.8445687631908384
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.022949303999999997	0.8436586870309626
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0227273	0.8354974110656601
SOTOS SYNDROME 2	0.0227273	0.8354974110656601
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0227273	0.8354974110656601
SPONDYLOOCULAR SYNDROME; SOS	0.0227273	0.8354974110656601
FRONTOMETAPHYSEAL DYSPLASIA	0.0227273	0.8354974110656601
ATAXIA WITH VITAMIN E DEFICIENCY	0.022707949999999998	0.8347860694234887
SPINOCEREBELLAR ATAXIA 40; SCA40	0.022707949999999998	0.8347860694234887
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.022707949999999998	0.8347860694234887
NEPHROSIALIDOSIS	0.02265578	0.8328682041277742
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	0.8328682041277742
SPINAL ARACHNOIDITIS	0.02265578	0.8328682041277742
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	0.8328682041277742
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02265578	0.8328682041277742
OCCIPITAL HORN SYNDROME	0.022605844	0.8310324647870265
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.022601708999999998	0.8308804545704694
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8276268477466776
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8276268477466776
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8276268477466776
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8276268477466776
COSTELLO SYNDROME	0.022464619999999998	0.8258408104162769
XQ21 MICRODELETION SYNDROME	0.022344183	0.8214133244546136
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.022277173	0.8189499134240243
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.02206029	0.8109768948514638
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021920273	0.8058296120239752
PRADER-WILLI SYNDROME; PWS	0.021920273	0.8058296120239752
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021750422999999998	0.7995856131649157
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.021385449	0.7861684966527794
COFFIN-SIRIS SYNDROME 8; CSS8	0.021374719	0.7857740420884125
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.021374719	0.7857740420884125
X-LINKED ADRENOLEUKODYSTROPHY	0.02133178	0.7841955253559476
COFFIN-LOWRY SYNDROME	0.021307329	0.7832966615578738
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7825274200145954
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.02125721	0.7814541948000451
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02125721	0.7814541948000451
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.02125721	0.7814541948000451
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021251304	0.7812370793613543
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.021209004	0.77968205344591
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.021209004	0.77968205344591
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.02112675	0.7766582448962893
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7730750681592123
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7730750681592123
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7730750681592123
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7730750681592123
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7730750681592123
TRANSALDOLASE DEFICIENCY	0.0208333	0.7658704823694068
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0208333	0.7658704823694068
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0208333	0.7658704823694068
CLEFT LIP/PALATE	0.0208333	0.7658704823694068
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0208333	0.7658704823694068
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.0208333	0.7658704823694068
RIBOFLAVIN DEFICIENCY	0.0208333	0.7658704823694068
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0208333	0.7658704823694068
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0208333	0.7658704823694068
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7624718500790326
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7624718500790326
AYMÉ-GRIPP SYNDROME	0.020695764	0.7608144056718524
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.02066345	0.7596264835103472
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.020604439999999998	0.7574571672155395
MULTIPLE SYSTEM ATROPHY	0.020604439999999998	0.7574571672155395
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020580274000000003	0.7565687805424279
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02053611	0.7549452305535465
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.7535890862031742
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.02024799	0.7443534086443783
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.020080339	0.7381902490758165
SMITH-MAGENIS SYNDROME	0.020034973	0.7365225113528842
BAND HETEROTOPIA; BH	0.019954873	0.7335778878108725
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7335778878108725
PITT-HOPKINS SYNDROME	0.019634413	0.721797187932308
BRAIN-LUNG-THYROID SYNDROME	0.019566554	0.7193025660978839
RIDDLE SYNDROME	0.019566554	0.7193025660978839
PERMANENT NEONATAL DIABETES MELLITUS	0.019551154	0.7187364337315048
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7135223178753098
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7135223178753098
HHHH SYNDROME	0.019409319	0.7135223178753098
COHEN SYNDROME	0.019350103	0.7113454286410557
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019294964	0.7093184174365241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.019259024	0.7079971968360261
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.019251964	0.707737658231699
UROCANIC ACIDURIA	0.01921271	0.7062946088869035
MARINESCO-SJOGREN SYNDROME; MSS	0.019199064000000002	0.7057929567913444
FRAXE INTELLECTUAL DISABILITY	0.01917522	0.7049164074313478
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.019117253999999997	0.7027854704995593
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.019114734	0.7026928306577883
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.019021	0.6992469961623212
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.019016264	0.6990728920787387
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.693618758156304
TOE, MISSHAPEN	0.0188679	0.693618758156304
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.693618758156304
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.693618758156304
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.693618758156304
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.693618758156304
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.693618758156304
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.693618758156304
VESICOURETERAL REFLUX 1	0.0188679	0.693618758156304
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.693618758156304
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.693618758156304
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.693618758156304
CARPAL DISPLACEMENT	0.0188679	0.693618758156304
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.693618758156304
VAN DEN BOSCH SYNDROME	0.0188679	0.693618758156304
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.693618758156304
THROMBOCYTOPENIA 3	0.0188679	0.693618758156304
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.693618758156304
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.693618758156304
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.693618758156304
KNUCKLE PADS	0.0188679	0.693618758156304
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.693618758156304
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.693618758156304
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.693618758156304
LETTERER-SIWE DISEASE	0.0188679	0.693618758156304
MONOPHALANGY OF GREAT TOE	0.0188679	0.693618758156304
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.693618758156304
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.693618758156304
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.693618758156304
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.693618758156304
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.693618758156304
RAYNAUD DISEASE	0.0188679	0.693618758156304
PUBIC BONE DYSPLASIA	0.0188679	0.693618758156304
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.693618758156304
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.693618758156304
TRACHEOBRONCHOMEGALY	0.0188679	0.693618758156304
SPINOCEREBELLAR ATAXIA 31	0.01865351	0.6857373868557816
ADULT-ONSET DYSTONIA-PARKINSONISM	0.018630873000000003	0.6849052090390462
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01853655	0.6814377218186569
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6814377218186569
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.01848375	0.6794966965624996
MOSAIC TRISOMY 15	0.01846839	0.6789320346697993
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.018442963	0.6779972913139599
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.018409494000000002	0.6767669092249764
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018292733999999998	0.6724745965562463
22Q11.2 DELETION SYNDROME	0.018101243	0.6654350346750562
TENORIO SYNDROME; TNORS	0.018085319000000002	0.6648496391034833
TRANSIENT NEONATAL DIABETES MELLITUS	0.018074054	0.664435516953661
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.018046739	0.6634313672401773
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.01794591	0.659724707475914
AMISH LETHAL MICROCEPHALY	0.01784585	0.6560463175681278
X SMALL RINGS	0.017839934	0.6558288345110174
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017815584	0.6549336836589827
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.017717829000000004	0.6513400297969437
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.017578563999999998	0.6462203918746184
JUVENILE HUNTINGTON DISEASE	0.017574429	0.6460683816580614
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0175439	0.6449460793844776
MYOPATHY, DISTAL 3	0.0175439	0.6449460793844776
PANDAS	0.0175439	0.6449460793844776
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0175439	0.6449460793844776
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.0175439	0.6449460793844776
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0175439	0.6449460793844776
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0175439	0.6449460793844776
DISTAL MYOPATHY, TATEYAMA TYPE	0.0175439	0.6449460793844776
DYSTONIA 7, TORSION	0.0175439	0.6449460793844776
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0175439	0.6449460793844776
EPISODIC ATAXIA TYPE 1	0.0175439	0.6449460793844776
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0175439	0.6449460793844776
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0175439	0.6449460793844776
TIBIAL MUSCULAR DYSTROPHY	0.0175439	0.6449460793844776
DISTAL MYOPATHY, WELANDER TYPE	0.0175439	0.6449460793844776
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.0175439	0.6449460793844776
MELAS	0.01736635	0.6384190143422284
ALCOHOL DEPENDENCE	0.0172414	0.6338256221877422
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6338256221877422
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6338256221877422
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6338256221877422
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6338256221877422
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6338256221877422
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6338256221877422
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6338256221877422
PALMOMENTAL REFLEX	0.0172414	0.6338256221877422
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6338256221877422
RHEUMATOID ARTHRITIS	0.0172414	0.6338256221877422
MOTION SICKNESS	0.0172414	0.6338256221877422
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6338256221877422
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6338256221877422
SICKLE CELL ANEMIA	0.0172414	0.6338256221877422
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6338256221877422
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6338256221877422
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6338256221877422
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6338256221877422
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6338256221877422
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6338256221877422
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6338256221877422
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6338256221877422
CERVICAL RIB	0.0172414	0.6338256221877422
TRANSSEXUALITY	0.0172414	0.6338256221877422
CARDIAC ARRHYTHMIA	0.0172414	0.6338256221877422
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6338256221877422
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6338256221877422
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6338256221877422
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6338256221877422
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6338256221877422
MYOPATHY, CONGENITAL	0.0172414	0.6338256221877422
DIASTEMATOMYELIA	0.0172414	0.6338256221877422
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6338256221877422
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6338256221877422
269800 SENILE PLAQUE FORMATION	0.0172414	0.6338256221877422
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6338256221877422
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6338256221877422
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6338256221877422
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6338256221877422
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6338256221877422
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6338256221877422
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6338256221877422
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6338256221877422
SPINOCEREBELLAR ATAXIA 20	0.017176410000000003	0.6314364700779379
SPINOCEREBELLAR ATAXIA TYPE 8	0.017176410000000003	0.6314364700779379
SPINOCEREBELLAR ATAXIA TYPE 28	0.017176410000000003	0.6314364700779379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.017176410000000003	0.6314364700779379
SPINOCEREBELLAR ATAXIA 38; SCA38	0.017176410000000003	0.6314364700779379
SPINOCEREBELLAR ATAXIA 45; SCA45	0.017176410000000003	0.6314364700779379
SPINOCEREBELLAR ATAXIA TYPE 30	0.017176410000000003	0.6314364700779379
SPINOCEREBELLAR ATAXIA 43; SCA43	0.017176410000000003	0.6314364700779379
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.017176410000000003	0.6314364700779379
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.017176410000000003	0.6314364700779379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.017176410000000003	0.6314364700779379
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.6311296557448338
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.017160279	0.6308434648050766
PYRIDOXINE-DEPENDENT EPILEPSY	0.017054724	0.6269630685756504
SPINOCEREBELLAR ATAXIA TYPE 21	0.017033009999999998	0.6261648219390556
SPINOCEREBELLAR ATAXIA TYPE 2	0.017033009999999998	0.6261648219390556
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.017033009999999998	0.6261648219390556
ARNOLD-CHIARI MALFORMATION TYPE I	0.017033009999999998	0.6261648219390556
SPINOCEREBELLAR ATAXIA TYPE 25	0.017033009999999998	0.6261648219390556
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016948053999999997	0.6230416828924247
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.016877373	0.620443319139954
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016847064000000002	0.619329104471604
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016847064000000002	0.619329104471604
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.016785239	0.6170563035916432
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.016653979	0.6122309442143093
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.016529213	0.6076443162387462
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016413353999999998	0.6033851259896335
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.602986112956862
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.602986112956862
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.016387633000000002	0.6024395746522544
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016383764000000002	0.6022973430856621
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.016375263999999997	0.6019848674288941
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.016371073	0.6018307985491866
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.016301509999999998	0.5992735345360412
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.5992735345360412
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.5992735345360412
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01629358	0.5989820131291979
PRIMARY DYSTONIA, DYT4 TYPE	0.016128999999999998	0.5929317491773344
OPTIC ATROPHY 2	0.016128999999999998	0.5929317491773344
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.016128999999999998	0.5929317491773344
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.016128999999999998	0.5929317491773344
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.016128999999999998	0.5929317491773344
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.015841630000000002	0.5823674986496459
PEHO-LIKE SYNDROME; PEHOL	0.015840373999999997	0.582321325776128
PROPIONIC ACIDEMIA	0.015749233	0.5789708147368963
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015721253999999997	0.5779422551603425
MONOSOMY 18Q	0.015705853	0.5773760860321214
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.015686154	0.5766519145071016
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01567665	0.5763025299609933
MEHMO SYNDROME	0.015627428999999998	0.5744930753372559
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.015536633	0.5711552471335046
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5687407661145811
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5687407661145811
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5687407661145811
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.015426632999999999	0.56711144451651
DESMOSTEROLOSIS	0.015294819999999999	0.5622657558405653
HYPERPROLINEMIA, TYPE I	0.015285362999999998	0.5619180991010297
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5578866852247798
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.015171473	0.5577312929187613
N-ACETYLASPARTATE DEFICIENCY; NACED	0.015171473	0.5577312929187613
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.015053214	0.5533838742489143
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.014933024	0.548965468462218
EPILEPSY, HOT WATER, 1	0.014925589999999999	0.5486921809289932
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5486851961790183
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5486851961790183
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.014898163999999998	0.5476839506510505
PERLMAN SYNDROME	0.014898163999999998	0.5476839506510505
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.014835992999999999	0.5453984301737671
SMITH-MAGENIS SYNDROME; SMS	0.014759403	0.5425828406970797
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014750472999999998	0.5422545574482636
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014665173	0.5391187723279942
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.014633833	0.5379666562005704
JOUBERT SYNDROME 31; JBTS31	0.014630054	0.5378277331997556
ANGELMAN SYNDROME (TYPE 1)	0.014625919	0.5376757229831987
ANGELMAN SYNDROME (TYPE 2)	0.014625919	0.5376757229831987
WITTEVEEN-KOLK SYNDROME	0.014529813000000003	0.5341426893985725
KOOLEN-DE VRIES SYNDROME	0.014529812999999999	0.5341426893985723
WARBURG MICRO SYNDROME 2; WARBM2	0.01444966	0.5311961174789362
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.014417779	0.5300241131950053
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014378568999999999	0.5285826813712565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5236413383824989
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.014218762999999999	0.5227079184529706
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.01421455	0.5225530408127397
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.014209053999999999	0.5223509977292579
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.014209053999999999	0.5223509977292579
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014209053999999999	0.5223509977292579
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.014209053999999999	0.5223509977292579
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014209053999999999	0.5223509977292579
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.014209053999999999	0.5223509977292579
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.014166754	0.5207959718138137
DANDY-WALKER SYNDROME	0.0140845	0.517772163264193
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.0140845	0.517772163264193
EPISODIC ATAXIA TYPE 5	0.0140845	0.517772163264193
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.0140845	0.517772163264193
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.0140845	0.517772163264193
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0140845	0.517772163264193
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.014039414	0.5161147188570127
WIEDEMANN-STEINER SYNDROME; WDSTS	0.013968323	0.5135012827493329
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013960649	0.5132191723740347
BANGSTAD SYNDROME	0.013923318999999998	0.5118468528131944
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013869853	0.5098813441702833
YUNIS-VARON SYNDROME	0.01385902	0.5094831031361933
XQ28 (MECP2) DUPLICATION	0.013835193000000003	0.5086071787275104
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.013756694000000002	0.5057214108944971
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.503585768446936
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.503585768446936
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.503585768446936
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.503585768446936
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.503585768446936
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.503585768446936
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.503585768446936
MEVALONIC ACIDURIA; MEVA	0.013677344	0.5028043587339649
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.013671174	0.5025775381689934
RING CHROMOSOME 14 SYNDROME	0.013671173999999998	0.5025775381689934
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671173999999998	0.5025775381689934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.5022954277936951
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.01364756	0.5017094440326507
ADENYLOSUCCINASE DEFICIENCY	0.013622592999999999	0.5007916111241187
SPINOCEREBELLAR ATAXIA 47; SCA47	0.013571979	0.49893094725451365
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.013516954	0.496908126899967
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516953999999998	0.4969081268999669
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516953999999998	0.4969081268999669
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516953999999998	0.4969081268999669
KRABBE DISEASE	0.013451114	0.4944877272244858
STICKLER SYNDROME	0.013442840000000001	0.49418355974400396
MOWAT-WILSON SYNDROME	0.013422769	0.49344571281377025
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.013328434	0.4899777844512776
INFANTILE DYSTONIA-PARKINSONISM	0.013328434	0.4899777844512776
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.013324299	0.48982577423472057
KOOLEN-DE VRIES SYNDROME; KDVS	0.013302822999999998	0.4890362769165153
SCHAAF-YANG SYNDROME; SHFYNG	0.013279213	0.4881683298275404
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.013279213	0.4881683298275404
FUMARASE DEFICIENCY; FMRD	0.013266844	0.48771362260418033
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013257432999999999	0.48736765690937545
MEHMO SYNDROME; MEHMO	0.013257432999999999	0.48736765690937545
COFS SYNDROME	0.013224399000000001	0.48615326622165006
PEHO SYNDROME; PEHO	0.013218483	0.48593578316453956
TEMPLE-BARAITSER SYNDROME	0.013151579	0.4834762688891995
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.013135173000000002	0.4828731541097958
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.013050322999999999	0.479753911818414
48,XXYY SYNDROME	0.013042393000000001	0.4794623904115706
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.012991772999999998	0.4776015059709136
RAYNAUD-CLAES SYNDROME; MRXSRC	0.012991772999999998	0.4776015059709136
15Q26 OVERGROWTH SYNDROME	0.012987559999999999	0.47744662833068263
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.4768525569644042
NEONATAL ADRENOLEUKODYSTROPHY	0.012963699	0.4765694540193727
ALLAN-HERNDON-DUDLEY SYNDROME	0.01293309	0.4754442107984309
DISTAL MONOSOMY 10Q	0.012816203	0.4711472293757704
LYSOSOMAL ACID LIPASE DEFICIENCY	0.012815754	0.4711307233087247
6Q TERMINAL DELETION SYNDROME	0.012794133	0.47033589552343336
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.012794133	0.47033589552343336
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.012794133	0.47033589552343336
JABERI-ELAHI SYNDROME; JABELS	0.012794133	0.47033589552343336
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.012794133	0.47033589552343336
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.012761404	0.4691327171975096
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.012751133000000001	0.46875513631860827
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012737794	0.4682647701085347
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.01272129	0.4676580526686176
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01268503	0.46632506827868825
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.012665073	0.4655914121984395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.012665073	0.4655914121984395
WHIM SYNDROME	0.012589619000000002	0.462817584174233
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.012566093	0.46195272507998375
BIOTINIDASE DEFICIENCY	0.012508904000000001	0.45985035209940833
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.012494863000000002	0.45933417907626994
SECONDARY SYRINGOMYELIA	0.012446218999999998	0.45754593603535076
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.012357074	0.45426880163269645
TEMPLE SYNDROME	0.0122702	0.451075153373162
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.012268599000000002	0.45101629766416373
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012195779	0.44833930033171326
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.012177803	0.44767846946041234
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.012123654000000001	0.4456878524794338
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012119519	0.44553584226287674
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.012048200000000002	0.4429140244552273
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.012048200000000002	0.4429140244552273
UNVERRICHT-LUNDBORG DISEASE	0.012048200000000002	0.4429140244552273
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.44260721012212323
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.44260721012212323
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.44260721012212323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.44260721012212323
WIEDEMANN-STEINER SYNDROME	0.012020539	0.44189715514442107
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.011997409	0.44104685373959296
21Q22.11Q22.12 MICRODELETION SYNDROME	0.011997409	0.44104685373959296
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.011997408999999999	0.4410468537395929
BOWEN-CONRADI SYNDROME	0.011997408999999999	0.4410468537395929
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.011974014	0.44018681044664215
WOLF-HIRSCHHORN SYNDROME	0.011958333	0.4396103480026686
MYOPATHY AND DIABETES MELLITUS	0.011904799999999998	0.43764237631634506
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.011904799999999998	0.43764237631634506
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.011904799999999998	0.43764237631634506
SPINOCEREBELLAR ATAXIA TYPE 11	0.011904799999999998	0.43764237631634506
SPINOCEREBELLAR ATAXIA TYPE 32	0.011904799999999998	0.43764237631634506
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.011904799999999998	0.43764237631634506
WOLFRAM-LIKE SYNDROME	0.011904799999999998	0.43764237631634506
CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	0.011904799999999998	0.43764237631634506
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.011904799999999998	0.43764237631634506
PIERPONT SYNDROME	0.011890573	0.43711936559059983
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.011879924	0.43672788873543283
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.011873993000000001	0.4365098542506929
EMANUEL SYNDROME	0.011842473000000001	0.4353511209917141
46,XX GONADAL DYSGENESIS	0.01180093	0.43382392379064305
ALG11-CDG	0.011775523	0.43288991567164314
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011749349	0.4319277112198503
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.011736709	0.4314630415373156
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.011707160000000001	0.430376765868865
SPINOCEREBELLAR ATAXIA 48; SCA48	0.011707160000000001	0.430376765868865
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.011707160000000001	0.430376765868865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.011707160000000001	0.430376765868865
SPINOCEREBELLAR ATAXIA TYPE 18	0.011707160000000001	0.430376765868865
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011700653	0.4301375565631487
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.011671503	0.4290659488696451
AICARDI-GOUTIERES SYNDROME 5	0.011636384	0.42777490974140664
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.011602803	0.4265404103261221
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.011578100000000001	0.42563228254387103
HOLOPROSENCEPHALY	0.011565293	0.42516147363372697
1P36 DELETION SYNDROME	0.011565293	0.42516147363372697
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.011520259	0.4235059408423293
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.42255164018656055
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.42255164018656055
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.42255164018656055
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.011466442999999998	0.42152756555472765
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.011412779	0.41955477806710584
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.011345019	0.41706379565503704
GLYCOGEN STORAGE DISEASE IXC	0.011327990000000001	0.4164377782480844
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.4164377782480844
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.4164377782480844
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.4164377782480844
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.4164377782480844
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.011281914	0.41474393961735123
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.4145919294007942
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.4145919294007942
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011237353	0.4131057951772067
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.011229969	0.4128343457360804
XP21 MICRODELETION SYNDROME	0.011187973	0.41129049542059587
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.011187973	0.41129049542059587
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.011187973	0.41129049542059587
GLYCEROL KINASE DEFICIENCY; GKD	0.011187973	0.41129049542059587
ALSTRÖM SYNDROME	0.011187973	0.41129049542059587
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011155099	0.41008198662758594
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.011130084	0.40916238915063946
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.011041609	0.40590988518210674
COHEN SYNDROME	0.011041609	0.40590988518210674
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.011019739	0.4051059036981642
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.011019739	0.4051059036981642
BOHRING-OPITZ SYNDROME	0.010934773	0.4019823970331136
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.010920889	0.4014719956191649
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.010882023999999999	0.4000432466308967
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.01086884	0.3995585785063289
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.3981355276035665
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.010797684	0.39694275287892106
2P15P16.1 MICRODELETION SYNDROME	0.010797684	0.39694275287892106
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.39468836968178844
GAUCHER DISEASE TYPE 3	0.01073636	0.39468836968178844
MERRF	0.01073636	0.39468836968178844
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.010695934	0.393202235458201
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.010691799	0.393050225241644
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.010663582999999999	0.3920129531085428
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.010652934	0.3916214762533758
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.010652919	0.3916209248257462
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.010652919	0.3916209248257462
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010647003	0.3914034417686359
RECURRENT ACUTE PANCREATITIS	0.010642419	0.3912349254850331
MARDEN-WALKER SYNDROME	0.010477694	0.38517933106608354
2Q32Q33 MICRODELETION SYNDROME	0.010477694	0.38517933106608354
1Q44 MICRODELETION SYNDROME	0.010446114	0.38401839209658634
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.010396893	0.38220893747284923
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.010396893	0.38220893747284923
2Q31.1 MICRODELETION SYNDROME	0.010396893	0.38220893747284923
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.010393353999999999	0.3820788373141078
JACOBSEN SYNDROME	0.010338303	0.3800550611516699
RUBINSTEIN-TAYBI SYNDROME	0.010338303	0.3800550611516699
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.010336469999999999	0.37998767669533395
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.010323829999999999	0.37952300701279934
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.010323829999999999	0.37952300701279934
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010298423	0.3785889988937995
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010298423	0.3785889988937995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010298423	0.3785889988937995
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.010298423	0.3785889988937995
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.010298423	0.3785889988937995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010298423	0.3785889988937995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010298423	0.3785889988937995
AICARDI-GOUTIERES SYNDROME 7	0.010298423	0.3785889988937995
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.010298423	0.3785889988937995
MONOSOMY 5P	0.010265719999999999	0.37738677637576695
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010184083000000002	0.3743856498826435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.010150423	0.37314824628184307
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.010118028999999999	0.3719573831729801
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.010101	0.3713313657660274
ATYPICAL WERNER SYNDROME	0.010101	0.3713313657660274
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660274
H SYNDROME	0.010101	0.3713313657660274
MANDIBULOACRAL DYSPLASIA	0.010101	0.3713313657660274
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.010101	0.3713313657660274
NEUTRAL LIPID STORAGE MYOPATHY	0.010101	0.3713313657660274
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660274
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010101	0.3713313657660274
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.010101	0.3713313657660274
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.010101	0.3713313657660274
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010101	0.3713313657660274
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.010101	0.3713313657660274
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.010101	0.3713313657660274
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.010101	0.3713313657660274
APOLIPOPROTEIN C-II DEFICIENCY	0.010101	0.3713313657660274
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.010101	0.3713313657660274
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.010101	0.3713313657660274
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660274
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660274
LYSOSOMAL ACID LIPASE DEFICIENCY	0.010101	0.3713313657660274
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.010101	0.3713313657660274
LCAT DEFICIENCY	0.010101	0.3713313657660274
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.010101	0.3713313657660274
ACQUIRED GENERALIZED LIPODYSTROPHY	0.010101	0.3713313657660274
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.010101	0.3713313657660274
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.010101	0.3713313657660274
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.010101	0.3713313657660274
TANGIER DISEASE	0.010101	0.3713313657660274
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.010101	0.3713313657660274
PROTOPORPHYRIA, ERYTHROPOIETIC	0.010101	0.3713313657660274
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.010101	0.3713313657660274
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.010101	0.3713313657660274
HYPERLIPOPROTEINEMIA, TYPE IV	0.010101	0.3713313657660274
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.010101	0.3713313657660274
ALAGILLE SYNDROME 1; ALGS1	0.010101	0.3713313657660274
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.010101	0.3713313657660274
CHOLESTERYL ESTER STORAGE DISEASE	0.010101	0.3713313657660274
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.010101	0.3713313657660274
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.010101	0.3713313657660274
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.010101	0.3713313657660274
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.3713313657660274
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.010101	0.3713313657660274
HYPERLIPIDEMIA DUE TO HEPATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.010101	0.3713313657660274
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.010101	0.3713313657660274
GLYCOGEN STORAGE DISEASE IXA	0.010101	0.3713313657660274
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01002304	0.3684654125658373
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.009939814	0.3654058715058192
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009936023	0.3652665073629008
MARDEN-WALKER SYNDROME	0.009935679	0.3652538612892621
NEONATAL MARFAN SYNDROME	0.009932139999999999	0.3651237611305208
6Q16 MICRODELETION SYNDROME	0.009855474	0.36230537775384347
CHROMOSOME 9P DELETION SYNDROME	0.009855474	0.36230537775384347
TOLUENE EMBRYOPATHY	0.009855474	0.36230537775384347
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.009835123	0.36155723750785745
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009835123	0.36155723750785745
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3604430228395075
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3604430228395075
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3604430228395075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3604430228395075
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3604430228395075
COFFIN-SIRIS SYNDROME 5	0.009792123	0.3599764783030323
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.009760543	0.3588155393335351
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.009760543	0.3588155393335351
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.009760543	0.3588155393335351
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.009757004	0.3586854391747938
RETINITIS PIGMENTOSA 59; RP59	0.009752868999999999	0.3585334289582367
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.009752868999999999	0.3585334289582367
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.009752868999999999	0.3585334289582367
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.009707783	0.35687598455105657
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.009707783	0.35687598455105657
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.009707783	0.35687598455105657
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.009707783	0.35687598455105657
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.009707783	0.35687598455105657
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.009707783	0.35687598455105657
WOLFRAM SYNDROME	0.009638529000000002	0.3543300799470807
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.009606323	0.35314612806450857
HALL-RIGGS SYNDROME	0.009580149	0.3521839236127157
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00957661	0.35205382345397435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009474284	0.3482921312122781
PYRUVATE DEHYDROGENASE DEFICIENCY	0.009470963	0.34817004513508687
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.009425929	0.34651451234368913
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.009425929	0.34651451234368913
COG8-CDG	0.009425929	0.34651451234368913
CLASSICAL EHLERS-DANLOS SYNDROME	0.00939426	0.3453503015702564
CONGENITAL HYPOTHYROIDISM	0.009392554000000001	0.3452875858678511
NIEMANN-PICK DISEASE, TYPE A	0.009392554000000001	0.3452875858678511
GM2-GANGLIOSIDOSIS, AB VARIANT	0.009356213	0.34395162376872196
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00930992	0.3422498078182807
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3403874529039448
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3403874529039448
CARNOSINASE DEFICIENCY	0.00925926	0.3403874529039448
CARNOSINEMIA	0.00925926	0.3403874529039448
GAUCHER DISEASE TYPE 2	0.00925926	0.3403874529039448
PAINE SYNDROME	0.00925926	0.3403874529039448
HYDROXYLYSINURIA	0.00925926	0.3403874529039448
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3403874529039448
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3403874529039448
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3403874529039448
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3403874529039448
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3403874529039448
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3403874529039448
DISTAL TRISOMY 17Q	0.009254242999999999	0.3402030187427678
10Q22.3Q23.3 MICRODELETION SYNDROME	0.009254242999999999	0.3402030187427678
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.009254242999999999	0.3402030187427678
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009250703999999998	0.3400729185840265
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009241059	0.33971835061820005
HENNEKAM-BEEMER SYNDROME	0.009175819	0.3373200080479025
ADRENOMYODYSTROPHY	0.009175819	0.3373200080479025
CONO-SPONDYLAR DYSPLASIA	0.009175819	0.3373200080479025
TRISOMY 13	0.009175819	0.3373200080479025
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.009175819	0.3373200080479025
4Q21 MICRODELETION SYNDROME	0.009175819	0.3373200080479025
DPM1-CDG	0.009175819	0.3373200080479025
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009169903	0.3371025249907922
8P23.1 MICRODELETION SYNDROME	0.009169903	0.3371025249907922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.009162229	0.3368204146154938
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.009143023	0.3361143666785666
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.009100023	0.3345336074737414
SARCOSINEMIA	0.009064904	0.33324256834550287
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.009064904	0.33324256834550287
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00906345	0.33318911662727463
LISSENCEPHALY, X-LINKED, 1; LISX1	0.009060769	0.33309055812894584
CRANIOFACIAL DYSSYNOSTOSIS	0.00903873	0.33228036389370996
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.33228036389370996
MUCOLIPIDOSIS TYPE II	0.00903873	0.33228036389370996
TRISOMY XQ28	0.00903873	0.33228036389370996
RING CHROMOSOME 7 SYNDROME	0.00903873	0.33228036389370996
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009015683	0.33143311372176565
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.008892913	0.32691986238277987
ALLAN-HERNDON-DUDLEY SYNDROME	0.00888451	0.3266109526246835
DISTAL MONOSOMY 19P13.3	0.008849913	0.32533910317795467
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.008849913	0.32533910317795467
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.008847	0.32523201593228834
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.008847	0.32523201593228834
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.008814794	0.3240480640497162
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.008810659	0.32389605383315917
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.008765573	0.322238609425979
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.008755823999999999	0.32188021822858726
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008708688999999999	0.3201474488072051
CHROMOSOME 13Q14 DELETION SYNDROME	0.00867357	0.3188564096789666
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0086344	0.3174164483288968
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008628484	0.3171989652717865
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.008624349	0.31704695505522945
ACROCALLOSAL SYNDROME; ACLS	0.008624349	0.31704695505522945
20Q13.33 MICRODELETION SYNDROME	0.008624349	0.31704695505522945
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00862081	0.3169168548964881
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.008532074	0.3136547560872005
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00851935	0.31318699840994013
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00851935	0.31318699840994013
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.31226916550140826
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.31226916550140826
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.31226916550140826
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.31226916550140826
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008458923	0.3109655905850571
NEURAMINIDASE DEFICIENCY	0.008347359	0.30686429244721714
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.008308494	0.30543554345894897
ARTERIAL TORTUOSITY SYNDROME	0.008308494	0.30543554345894897
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.008308494	0.30543554345894897
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.008308494	0.30543554345894897
DISTAL TRISOMY 15Q	0.008304358999999999	0.30528353324239194
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.008304358999999999	0.30528353324239194
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.008304358999999999	0.30528353324239194
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00826924	0.30399249411415347
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00826924	0.30399249411415347
OROFACIODIGITAL SYNDROME TYPE 6	0.008243973	0.30306363265302977
TRISOMY 17P	0.008224154	0.3023350497069732
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.008224154	0.3023350497069732
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.008220019	0.30218303949041625
RING CHROMOSOME 10 SYNDROME	0.008220019	0.30218303949041625
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.008220019	0.30218303949041625
COFFIN-LOWRY SYNDROME; CLS	0.008220019	0.30218303949041625
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.008220019	0.30218303949041625
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.008167269999999999	0.3002438890881994
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.008167269999999999	0.3002438890881994
GORLIN SYNDROME	0.008167269999999999	0.3002438890881994
FLOATING-HARBOR SYNDROME	0.008165564	0.30018117338579403
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008165564	0.30018117338579403
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.008161429	0.300029163169237
OCULOCEREBRORENAL SYNDROME OF LOWE	0.008161429	0.300029163169237
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.008161429	0.300029163169237
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.008129223	0.2988452112866649
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008129223	0.2988452112866649
HEART AND BRAIN MALFORMATION SYNDROME	0.008129223	0.2988452112866649
AICARDI-GOUTIÈRES SYNDROME	0.008129223	0.2988452112866649
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.008129223	0.2988452112866649
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.008129223	0.2988452112866649
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.008129223	0.2988452112866649
LISSENCEPHALY 8; LIS8	0.008129223	0.2988452112866649
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.008129223	0.2988452112866649
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.008129223	0.2988452112866649
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008129223	0.2988452112866649
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.008129223	0.2988452112866649
LISSENCEPHALY 1; LIS1	0.008129223	0.2988452112866649
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.008129223	0.2988452112866649
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00808293	0.2971433953362237
SIFRIM-HITZ-WEISS SYNDROME	0.00808293	0.2971433953362237
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00808293	0.2971433953362237
ATAXIA-PANCYTOPENIA SYNDROME	0.00805605	0.2961552370239981
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.008013049999999999	0.29457447781917284
SMITH-LEMLI-OPITZ SYNDROME	0.007993863000000002	0.29386912835724316
COFFIN-SIRIS SYNDROME	0.007993863	0.29386912835724316
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2923656057824025
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.2923656057824025
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.2922135955658455
FRYNS SYNDROME	0.007948829	0.2922135955658455
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.2922135955658455
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.2922135955658455
SECKEL SYNDROME 7; SCKL7	0.007948829	0.2922135955658455
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007948829	0.2922135955658455
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.007948829	0.2922135955658455
1Q41Q42 MICRODELETION SYNDROME	0.007948829	0.2922135955658455
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.2922135955658455
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.007948829	0.2922135955658455
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.2922135955658455
LISSENCEPHALY 5; LIS5	0.007948829	0.2922135955658455
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.2922135955658455
LOWRY-MACLEAN SYNDROME	0.007948829	0.2922135955658455
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.2922135955658455
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.2922135955658455
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.2922135955658455
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.2922135955658455
CROME SYNDROME	0.007948829	0.2922135955658455
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.2922135955658455
KEPPEN-LUBINSKY SYNDROME	0.007948829	0.2922135955658455
RING CHROMOSOME 22 SYNDROME	0.007846503000000001	0.2884519033241492
FOLATE MALABSORPTION, HEREDITARY	0.007839643	0.2881997170882166
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007839643	0.2881997170882166
JOUBERT SYNDROME	0.007839643	0.2881997170882166
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.007839643	0.2881997170882166
GALACTOSEMIA	0.007839643	0.2881997170882166
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.007839643	0.2881997170882166
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.007839643	0.2881997170882166
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.007838829	0.28816979294885087
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.007838829	0.28816979294885087
%608572 BURN-MCKEOWN SYNDROME	0.00783646	0.2880827041452176
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00783646	0.2880827041452176
CONGENITAL ADRENAL HYPERPLASIA	0.00783646	0.2880827041452176
MARFAN SYNDROME	0.007762939999999999	0.28537997352338623
SHPRINTZEN-GOLDBERG SYNDROME	0.007762939999999999	0.28537997352338623
ARTERIAL TORTUOSITY SYNDROME	0.007762939999999999	0.28537997352338623
FRYNS-SMEETS-THIRY SYNDROME	0.007762939999999999	0.28537997352338623
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.007762939999999999	0.28537997352338623
CHROMOSOME 10Q26 DELETION SYNDROME	0.007733163	0.2842853161549658
BARAITSER-WINTER SYNDROME 1; BRWS1	0.007733163	0.2842853161549658
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.007733163	0.2842853161549658
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.007692283	0.2827824920551227
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0076786	0.28227947977141055
OPSISMODYSPLASIA	0.0076786	0.28227947977141055
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.007665923	0.2818134499007229
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.007665923	0.2818134499007229
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.007665923	0.2818134499007229
GLASS SYNDROME	0.007622923	0.2802326906958977
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.007622923	0.2802326906958977
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.007622923	0.2802326906958977
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.007587804	0.2789416515676592
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.007587804	0.2789416515676592
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.007587804	0.2789416515676592
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007587804	0.2789416515676592
PELGER-HUET ANOMALY; PHA	0.007587804	0.2789416515676592
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2789416515676592
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.007587804	0.2789416515676592
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2789416515676592
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2789416515676592
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007587804	0.2789416515676592
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.007587804	0.2789416515676592
HYPERMANGANESEMIA WITH DYSTONIA 2	0.007587804	0.2789416515676592
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.007587804	0.2789416515676592
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.2789416515676592
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.007587804	0.2789416515676592
W SYNDROME	0.007587804	0.2789416515676592
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.2789416515676592
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0075836689999999995	0.2787896413511022
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0075836689999999995	0.2787896413511022
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2787896413511022
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0075836689999999995	0.2787896413511022
WARBURG MICRO SYNDROME 3; WARBM3	0.0075836689999999995	0.2787896413511022
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0075836689999999995	0.2787896413511022
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0075836689999999995	0.2787896413511022
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0075836689999999995	0.2787896413511022
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2787896413511022
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0075789429999999994	0.27861590488593924
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0075789429999999994	0.27861590488593924
SALLA DISEASE	0.0075789429999999994	0.27861590488593924
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.007538583	0.27713219694392194
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.007538583	0.27713219694392194
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.007538583	0.27713219694392194
WILSON-TURNER SYNDROME	0.007538583	0.27713219694392194
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.007538583	0.27713219694392194
SHUKLA-VERNON SYNDROME; SHUVER	0.007538583	0.27713219694392194
49,XXXXY SYNDROME	0.0075167129999999995	0.2763282154599795
48,XXXY SYNDROME	0.0075167129999999995	0.2763282154599795
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.007513173999999999	0.27619811530123817
PERMANENT CONGENITAL HYPOTHYROIDISM	0.007513173999999999	0.27619811530123817
ATHYREOSIS	0.007513173999999999	0.27619811530123817
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.007509039	0.2760461050846812
CARDIOFACIOCUTANEOUS SYNDROME	0.007452444000000001	0.2739655686382374
CHARGE SYNDROME	0.007452444000000001	0.2739655686382374
OHDO SYNDROME	0.007448309	0.27381355842168037
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007442173	0.273587987759336
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.007442173	0.273587987759336
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.007442173	0.273587987759336
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.27231003584683977
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.27231003584683977
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.27231003584683977
DISTAL MONOSOMY 10P	0.00740741	0.27231003584683977
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.27231003584683977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.27231003584683977
KID SYNDROME	0.00740741	0.27231003584683977
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.27231003584683977
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.27231003584683977
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.007362493000000001	0.270658804190953
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.007362493000000001	0.270658804190953
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00735931	0.2705417912479539
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.007298224000000001	0.2682961573692109
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00729741	0.26826623322984516
MAPLE SYRUP URINE DISEASE; MSUD	0.007294089	0.2681441471526539
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.007294089	0.2681441471526539
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007294089	0.2681441471526539
FAMILIAL DYSAUTONOMIA	0.007294089	0.2681441471526539
CUTIS LAXA	0.007191744	0.26438175643596007
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.007124504	0.2619098901817172
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.007124504	0.2619098901817172
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.007124504	0.2619098901817172
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.007124504	0.2619098901817172
OPTIC ATROPHY 11; OPA11	0.007124504	0.2619098901817172
PEROXISOME BIOGENESIS DISORDER 5B	0.007124504	0.2619098901817172
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.007124504	0.2619098901817172
JOUBERT SYNDROME 24	0.007124504	0.2619098901817172
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.007124504	0.2619098901817172
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.007124504	0.2619098901817172
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.007120369	0.26175787996516015
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.007120369	0.26175787996516015
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.007081504	0.2603291309768919
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.007081504	0.2603291309768919
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.007081504	0.2603291309768919
16P13.11 MICRODUPLICATION SYNDROME	0.007081504	0.2603291309768919
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.007081504	0.2603291309768919
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.007081504	0.2603291309768919
DISTAL TRISOMY 18Q	0.007081504	0.2603291309768919
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007081504	0.2603291309768919
CLASSIC HOMOCYSTINURIA	0.007077369	0.26017712076033495
HARROD SYNDROME	0.007077369	0.26017712076033495
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2588860816320965
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.2588860816320965
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.2588860816320965
OLIVER SYNDROME	0.00704225	0.2588860816320965
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.2588860816320965
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2588860816320965
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.2588860816320965
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.2588860816320965
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2588860816320965
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.00704225	0.2588860816320965
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00704225	0.2588860816320965
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00704225	0.2588860816320965
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.2588860816320965
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.2588860816320965
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.2588860816320965
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2588860816320965
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2588860816320965
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.2588860816320965
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.2588860816320965
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.2588860816320965
NEURONAL CEROID LIPOFUSCINOSIS	0.007033388999999999	0.2585603349503765
CEREBELLOFACIODENTAL SYNDROME	0.006997164	0.25722863722491623
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.006997164	0.25722863722491623
3Q29 MICRODELETION SYNDROME	0.006997164	0.25722863722491623
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.006997164	0.25722863722491623
YUNIS-VARON SYNDROME	0.006997164	0.25722863722491623
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.006997164	0.25722863722491623
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006997164	0.25722863722491623
GOLDBERG-SHPRINTZEN SYNDROME	0.006997164	0.25722863722491623
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006997164	0.25722863722491623
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.006997164	0.25722863722491623
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0069930289999999996	0.2570766270083592
ATKIN-FLAITZ SYNDROME	0.0069930289999999996	0.2570766270083592
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0069930289999999996	0.2570766270083592
CLARK-BARAITSER SYNDROME	0.0069930289999999996	0.2570766270083592
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0069930289999999996	0.2570766270083592
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0069930289999999996	0.2570766270083592
CRONKHITE-CANADA SYNDROME	0.0069930289999999996	0.2570766270083592
AYME-GRIPP SYNDROME; AYGRP	0.0069930289999999996	0.2570766270083592
C SYNDROME	0.006971158999999999	0.2562726455244167
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00696762	0.25614254536567543
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00696762	0.25614254536567543
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00696762	0.25614254536567543
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.006906890000000001	0.25390999870267467
MOEBIUS SYNDROME	0.006906890000000001	0.25390999870267467
DUBOWITZ SYNDROME	0.006906890000000001	0.25390999870267467
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.006900754	0.2536844280403303
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006827603	0.2509952625381869
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006827603	0.2509952625381869
NEPHROGENIC DIABETES INSIPIDUS	0.006827603	0.2509952625381869
PRADER-WILLI-LIKE SYNDROME	0.006827603	0.2509952625381869
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006827603	0.2509952625381869
CHROMOSOME 19P13.13 DELETION SYNDROME	0.006827603	0.2509952625381869
DESANTO-SHINAWI SYNDROME	0.006827603	0.2509952625381869
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006827603	0.2509952625381869
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006827603	0.2509952625381869
ALEXANDER DISEASE	0.006816939000000001	0.2506032342553903
2Q23.1 MICRODELETION SYNDROME	0.006816939000000001	0.2506032342553903
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0067668730000000005	0.2487627158751861
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0067668730000000005	0.2487627158751861
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0067668730000000005	0.2487627158751861
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.006612653000000001	0.24309330460615966
ARGININOSUCCINIC ACIDURIA	0.006612653000000001	0.24309330460615966
BOUCHER-NEUHAUSER SYNDROME	0.00660531	0.24282336240055422
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00657895	0.24185432024615441
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00657895	0.24185432024615441
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00657895	0.24185432024615441
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00657895	0.24185432024615441
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00657895	0.24185432024615441
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00657895	0.24185432024615441
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00657895	0.24185432024615441
BEHR SYNDROME	0.00657895	0.24185432024615441
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00657895	0.24185432024615441
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00657895	0.24185432024615441
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00653595	0.2402735610413292
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00653595	0.2402735610413292
STICKLER SYNDROME, TYPE I	0.00653595	0.2402735610413292
BRITTLE CORNEA SYNDROME	0.00653595	0.2402735610413292
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00653595	0.2402735610413292
TRISOMY 1Q	0.00653595	0.2402735610413292
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00653595	0.2402735610413292
CUTIS LAXA-MARFANOID SYNDROME	0.00653595	0.2402735610413292
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00653595	0.2402735610413292
NAKAJO-NISHIMURA SYNDROME	0.00653595	0.2402735610413292
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00653595	0.2402735610413292
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00653595	0.2402735610413292
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.00653595	0.2402735610413292
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00653595	0.2402735610413292
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00653595	0.2402735610413292
MARFANOID HABITUS WITH SITUS INVERSUS	0.00653595	0.2402735610413292
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.00653595	0.2402735610413292
PAPILLON-LEFÈVRE SYNDROME	0.00653595	0.2402735610413292
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.00653595	0.2402735610413292
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00653595	0.2402735610413292
3Q27.3 MICRODELETION SYNDROME	0.00653595	0.2402735610413292
LOEYS-DIETZ SYNDROME 3; LDS3	0.00653595	0.2402735610413292
FAMILIAL VISCERAL MYOPATHY	0.00653595	0.2402735610413292
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00653595	0.2402735610413292
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00653595	0.2402735610413292
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.00653595	0.2402735610413292
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00653595	0.2402735610413292
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00653595	0.2402735610413292
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00653595	0.2402735610413292
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00653595	0.2402735610413292
HAIM-MUNK SYNDROME	0.00653595	0.2402735610413292
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.00653595	0.2402735610413292
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00653595	0.2402735610413292
LOEYS-DIETZ SYNDROME	0.00653595	0.2402735610413292
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00653595	0.2402735610413292
MOSAIC TRISOMY 1	0.00653595	0.2402735610413292
ANTLEY-BIXLER SYNDROME	0.00653595	0.2402735610413292
MARFAN SYNDROME; MFS	0.00653595	0.2402735610413292
601095 HARROD SYNDROME	0.00653595	0.2402735610413292
FRONTOMETAPHYSEAL DYSPLASIA	0.00653595	0.2402735610413292
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00653595	0.2402735610413292
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00653595	0.2402735610413292
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00653595	0.2402735610413292
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00653595	0.2402735610413292
ACHARD SYNDROME	0.00653595	0.2402735610413292
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00653595	0.2402735610413292
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00653595	0.2402735610413292
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00653595	0.2402735610413292
LOEYS-DIETZ SYNDROME 5	0.00653595	0.2402735610413292
PROLIDASE DEFICIENCY	0.00653595	0.2402735610413292
NON-DISTAL TRISOMY 13Q	0.00653595	0.2402735610413292
MARFANOID HYPERMOBILITY SYNDROME	0.00653595	0.2402735610413292
REFSUM DISEASE	0.00649197	0.2386567752313708
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00645161	0.2371730672893535
ACROMEGALY	0.00645161	0.2371730672893535
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00645161	0.2371730672893535
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.00645161	0.2371730672893535
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00645161	0.2371730672893535
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.00645161	0.2371730672893535
SATOYOSHI SYNDROME	0.00645161	0.2371730672893535
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00645161	0.2371730672893535
CLEIDOCRANIAL DYSPLASIA	0.00645161	0.2371730672893535
HURIEZ SYNDROME; HRZ	0.00645161	0.2371730672893535
PARANA HARD SKIN SYNDROME	0.00645161	0.2371730672893535
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00645161	0.2371730672893535
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00645161	0.2371730672893535
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00645161	0.2371730672893535
ERYTHROKERATODERMIA VARIABILIS	0.00645161	0.2371730672893535
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00645161	0.2371730672893535
ACROCRANIOFACIAL DYSOSTOSIS	0.00645161	0.2371730672893535
SAY SYNDROME	0.00645161	0.2371730672893535
SOMATOMAMMOTROPINOMA	0.00645161	0.2371730672893535
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00645161	0.2371730672893535
BASAN SYNDROME	0.00645161	0.2371730672893535
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00645161	0.2371730672893535
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00645161	0.2371730672893535
OTOFACIOCERVICAL SYNDROME 2	0.00645161	0.2371730672893535
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006364592999999999	0.2339741620864169
VICI SYNDROME	0.006362543000000001	0.23389880031037297
CHROMOSOME 16P13.3 DELETION SYNDROME	0.006362543000000001	0.23389880031037297
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.006362543000000001	0.23389880031037297
COFFIN-SIRIS SYNDROME 1; CSS1	0.006362543000000001	0.23389880031037297
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.006362543000000001	0.23389880031037297
KABUKI SYNDROME 1	0.006362543000000001	0.23389880031037297
METHYLMALONIC ACIDURIA, CBLA TYPE	0.006362543000000001	0.23389880031037297
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.006362543000000001	0.23389880031037297
SOTOS SYNDROME	0.006362543000000001	0.23389880031037297
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.006362543	0.2338988003103729
CANAVAN DISEASE	0.006362543	0.2338988003103729
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.006362543	0.2338988003103729
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.006362543	0.2338988003103729
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0062897230000000005	0.2312218029779225
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0062897230000000005	0.2312218029779225
PERIPHERAL HYPOTHYROIDISM	0.006286183999999999	0.23109170281918112
COFFIN-SIRIS SYNDROME 7; CSS7	0.006286183999999999	0.23109170281918112
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.006286183999999999	0.23109170281918112
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006286183999999999	0.23109170281918112
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006286183999999999	0.23109170281918112
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006286183999999999	0.23109170281918112
AU-KLINE SYNDROME; AUKS	0.006286183999999999	0.23109170281918112
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006282049	0.23093969260262415
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006282049	0.23093969260262415
JOUBERT SYNDROME 10	0.006225454	0.2288591561561804
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.006221319	0.22870714593962335
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.006215183	0.22848157527727903
PETTIGREW SYNDROME	0.006215183	0.22848157527727903
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0061355030000000005	0.22555239170889602
MONOSOMY 9Q22.3	0.006114483	0.2247796577906303
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0061144829999999996	0.22477965779063025
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.006071234	0.2231897448871539
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.006067098999999999	0.22303773467059682
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0059602629999999995	0.21911024652160374
JOUBERT SYNDROME WITH RENAL DEFECT	0.0059602629999999995	0.21911024652160374
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0059602629999999995	0.21911024652160374
RFT1-CDG	0.0059602629999999995	0.21911024652160374
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00595708	0.21899323357860473
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005885393000000001	0.21635788741310932
KLEEFSTRA SYNDROME	0.005885393000000001	0.21635788741310932
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.005885393000000001	0.21635788741310932
HOLOPROSENCEPHALY 2; HPE2	0.005885393000000001	0.21635788741310932
BAKER-GORDON SYNDROME; BAGOS	0.0058231739999999995	0.21407060236741118
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.0058211240000000004	0.2139952405913672
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0058211240000000004	0.2139952405913672
3C SYNDROME	0.0058211240000000004	0.2139952405913672
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0058211240000000004	0.2139952405913672
HYPOTONIA-CYSTINURIA SYNDROME	0.0058211240000000004	0.2139952405913672
MENKES DISEASE	0.005816989000000001	0.21384323037481023
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.005816989000000001	0.21384323037481023
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.005816989000000001	0.21384323037481023
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.005816989000000001	0.21384323037481023
CORNELIA DE LANGE SYNDROME	0.005816989000000001	0.21384323037481023
ACROCARDIOFACIAL SYNDROME	0.005816989000000001	0.21384323037481023
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.005816989000000001	0.21384323037481023
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.005816989000000001	0.21384323037481023
HYPOPHOSPHATASIA	0.005816989	0.21384323037481018
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.005816989	0.21384323037481018
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.005816989	0.21384323037481018
REVESZ SYNDROME	0.005810534	0.21360593268487654
COFFIN-SIRIS SYNDROME 6; CSS6	0.005748304	0.21131824325891674
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.005748304	0.21131824325891674
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00574063	0.21103613288361842
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.21103613288361842
SILVER-RUSSELL SYNDROME	0.00574063	0.21103613288361842
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.21103613288361842
GMS SYNDROME	0.0056799	0.20880358622061765
CRI-DU-CHAT SYNDROME	0.0056799	0.20880358622061765
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0056799	0.20880358622061765
MARTSOLF SYNDROME	0.0056799	0.20880358622061765
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005673764	0.20857801555827332
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.20857801555827332
HUNTINGTON DISEASE; HD	0.005669629000000001	0.20842600534171626
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.20842600534171626
ATYPICAL JUVENILE PARKINSONISM	0.005669629000000001	0.20842600534171626
RAPID-ONSET DYSTONIA-PARKINSONISM	0.005669629000000001	0.20842600534171626
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.005669629000000001	0.20842600534171626
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.005669629000000001	0.20842600534171626
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.005594084	0.20564883198989026
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005589949	0.20549682177333323
GITELMAN SYNDROME	0.005589949	0.20549682177333323
16P11.2P12.2 MICRODELETION SYNDROME	0.005573064	0.20487609807162455
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.005573064	0.20487609807162455
14Q12 MICRODELETION SYNDROME	0.005568929	0.20472408785506754
PALLISTER-KILLIAN SYNDROME	0.005568929	0.20472408785506754
LARSEN-LIKE SYNDROME	0.0055604240000000004	0.2044114283890899
XYLOSIDASE DEFICIENCY	0.005556289000000001	0.20425941817253288
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005556289000000001	0.20425941817253288
ASPARTYLGLUCOSAMINURIA; AGU	0.005556289	0.20425941817253285
CAMURATI-ENGELMANN DISEASE	0.00552568	0.20313417495159114
15Q11Q13 MICRODUPLICATION SYNDROME	0.005422383	0.19933678696133936
ISOLATED COMPLEX I DEFICIENCY	0.005418844	0.19920668680259804
CITRULLINEMIA TYPE I	0.005414708999999999	0.199054676586041
CHOREOACANTHOCYTOSIS	0.005414708999999999	0.199054676586041
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.0053439740000000005	0.19645432769410362
THYROID HYPOPLASIA	0.005343974	0.19645432769410356
THYROID HEMIAGENESIS	0.005343974	0.19645432769410356
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005343974	0.19645432769410356
THYROID ECTOPIA	0.005343974	0.19645432769410356
FAMILIAL THYROID DYSHORMONOGENESIS	0.005343974	0.19645432769410356
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.005343974	0.19645432769410356
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005343974	0.19645432769410356
LYNCH SYNDROME	0.005339839000000001	0.19630231747754656
HYPOPHOSPHATASIA, INFANTILE	0.005339839000000001	0.19630231747754656
ACUTE ADRENAL INSUFFICIENCY	0.005339839000000001	0.19630231747754656
FAMILIAL COLORECTAL CANCER TYPE X	0.005339839000000001	0.19630231747754656
GOLDENHAR SYNDROME	0.00527557	0.19393967065580447
PRADER-WILLI SYNDROME (TYPE 2)	0.00527557	0.19393967065580447
PRADER-WILLI SYNDROME (TYPE 1)	0.00527557	0.19393967065580447
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00527557	0.19393967065580447
NOONAN SYNDROME	0.00527557	0.19393967065580447
NEMALINE MYOPATHY 4	0.00527557	0.19393967065580447
ESOPHAGEAL ATRESIA	0.00527557	0.19393967065580447
STÜVE-WIEDEMANN SYNDROME	0.00527557	0.19393967065580447
MYOTONIC DYSTROPHY 1	0.00527557	0.19393967065580447
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00527557	0.19393967065580447
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.1935503627493138
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.1935503627493138
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.1935503627493138
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.1935503627493138
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00520275	0.191262673323354
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.005135553000000001	0.18879238782831598
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.005135553000000001	0.18879238782831598
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.005135553000000001	0.18879238782831598
SHASHI-PENA SYNDROME; SHAPNS	0.005135553000000001	0.18879238782831598
POTOCKI-LUPSKI SYNDROME	0.005135553000000001	0.18879238782831598
PETERS-PLUS SYNDROME; PTRPLS	0.005135553000000001	0.18879238782831598
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.005135553000000001	0.18879238782831598
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.005135553000000001	0.18879238782831598
CORNELIA DE LANGE SYNDROME 3	0.005135553000000001	0.18879238782831598
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.005135553000000001	0.18879238782831598
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.005135553000000001	0.18879238782831598
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.18852244562271056
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.18852244562271056
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00512821	0.18852244562271056
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.18852244562271056
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00512821	0.18852244562271056
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.18852244562271056
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00512821	0.18852244562271056
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00512821	0.18852244562271056
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.18852244562271056
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.18852244562271056
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.18852244562271056
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00512821	0.18852244562271056
CHIARI MALFORMATION TYPE I	0.00512821	0.18852244562271056
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00512821	0.18852244562271056
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.18852244562271056
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.18852244562271056
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.18852244562271056
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.18852244562271056
SUSAC SYNDROME	0.00512821	0.18852244562271056
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00512821	0.18852244562271056
SPINOCEREBELLAR ATAXIA TYPE 38	0.00512821	0.18852244562271056
SYRINGOMYELIA, ISOLATED	0.00512821	0.18852244562271056
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.18852244562271056
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00512821	0.18852244562271056
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.18852244562271056
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.18852244562271056
TURCOT SYNDROME WITH POLYPOSIS	0.00504853	0.1855932620543275
TYPHOID	0.00504853	0.1855932620543275
NEUROFERRITINOPATHY	0.00504853	0.1855932620543275
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00502751	0.18482052813606178
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00502751	0.18482052813606178
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00501487	0.18435585845352714
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00501487	0.18435585845352714
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00501487	0.18435585845352714
MONOSOMY 22Q13.3	0.004887493	0.17967324530857323
PHELAN-MCDERMID SYNDROME	0.004887493	0.17967324530857323
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004887493	0.17967324530857323
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004887493	0.17967324530857323
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004887493	0.17967324530857323
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004887493	0.17967324530857323
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004887493	0.17967324530857323
11Q22.2Q22.3 MICRODELETION SYNDROME	0.004887493	0.17967324530857323
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004887493	0.17967324530857323
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.004887493	0.17967324530857323
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004887493	0.17967324530857323
8P11.2 DELETION SYNDROME	0.004887493	0.17967324530857323
TETRASOMY 9P	0.004887493	0.17967324530857323
JOUBERT SYNDROME 1	0.004880964	0.1794332272423336
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.004876829	0.1792812170257766
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004874853	0.1792085756260386
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.1792085756260386
CHIARI MALFORMATION TYPE II	0.00487329	0.17915111686703528
JUVENILE DERMATOMYOSITIS	0.00479842	0.17639875775854083
POLYMYOSITIS	0.00479842	0.17639875775854083
INFANT BOTULISM	0.00479842	0.17639875775854083
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004733273	0.17400383403954672
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004733273	0.17400383403954672
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004733273	0.17400383403954672
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004733273	0.17400383403954672
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004733273	0.17400383403954672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004733273	0.17400383403954672
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004733273	0.17400383403954672
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004733273	0.17400383403954672
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.004733273	0.17400383403954672
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004733273	0.17400383403954672
611961 STEVENSON-CAREY SYNDROME	0.004658403	0.1712514749310523
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004658403	0.1712514749310523
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004658403	0.1712514749310523
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004658403	0.1712514749310523
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004658403	0.1712514749310523
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004658403	0.1712514749310523
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004658403	0.1712514749310523
FG SYNDROME TYPE 1	0.004658403	0.1712514749310523
WEAVER SYNDROME	0.004594134000000001	0.16888882810931022
OCULOFACIOCARDIODENTAL SYNDROME	0.004594134000000001	0.16888882810931022
PETERS PLUS SYNDROME	0.004594134000000001	0.16888882810931022
HYPOADRENOCORTICISM, FAMILIAL	0.004589999000000001	0.16873681789275322
SYSTEMIC SCLEROSIS	0.004589999000000001	0.16873681789275322
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.004589999000000001	0.16873681789275322
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004589999000000001	0.16873681789275322
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.004589999000000001	0.16873681789275322
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.004589999000000001	0.16873681789275322
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.004589999000000001	0.16873681789275322
SCLERODERMA	0.004589999000000001	0.16873681789275322
2Q33.1 DELETION SYNDROME	0.004589999000000001	0.16873681789275322
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.004483163	0.16480932974376009
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.004483163	0.16480932974376009
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.004483163	0.16480932974376009
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004483163	0.16480932974376009
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004483163	0.16480932974376009
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004483163	0.16480932974376009
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004483163	0.16480932974376009
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004483163	0.16480932974376009
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004346074	0.15976968558956753
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004346073999999999	0.1597696855895675
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004346073999999999	0.1597696855895675
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004346073999999999	0.1597696855895675
48,XYYY SYNDROME	0.004346073999999999	0.1597696855895675
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004346073999999999	0.1597696855895675
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004346073999999999	0.1597696855895675
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004346073999999999	0.1597696855895675
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004346073999999999	0.1597696855895675
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0043419389999999995	0.15961767537301047
DUPLICATION/INVERSION 15Q11	0.0043419389999999995	0.15961767537301047
NON-DISTAL MONOSOMY 10Q	0.00433541	0.15937765730677086
JOUBERT SYNDROME 3; JBTS3	0.00433541	0.15937765730677086
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.15930501590703286
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.15930501590703286
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.15915300569047583
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.15915300569047583
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.15915300569047583
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.15915300569047583
EPILEPSY-TELANGIECTASIA	0.004329299	0.15915300569047583
GAPO SYNDROME; GAPOS	0.004329299	0.15915300569047583
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0041953929999999995	0.1542303744792823
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0041953929999999995	0.1542303744792823
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004191854	0.15410027432054102
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004191853999999999	0.154100274320541
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004191853999999999	0.154100274320541
COCKAYNE SYNDROME	0.0041877189999999995	0.15394826410398396
PROPIONIC ACIDEMIA	0.004116984	0.15134791521204657
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.15134791521204657
PORPHYRIA	0.004112849	0.15119590499548954
MOWAT-WILSON SYNDROME; MOWS	0.004112849	0.15119590499548954
KAPUR-TORIELLO SYNDROME	0.004112849	0.15119590499548954
PORPHYRIA VARIEGATA	0.004112849	0.15119590499548954
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15119590499548954
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15119590499548954
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15119590499548954
HEREDITARY COPROPORPHYRIA	0.004112849	0.15119590499548954
ADIPOSIS DOLOROSA	0.004112849	0.15119590499548954
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15119590499548954
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15119590499548954
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.15119590499548954
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15119590499548954
ADDISON DISEASE	0.004112849	0.15119590499548954
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15119590499548954
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15119590499548954
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.14883325817374748
AORTIC ARCH DEFECTS	0.00404858	0.14883325817374748
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00404858	0.14883325817374748
INCLUSION BODY MYOSITIS	0.00404858	0.14883325817374748
APERT SYNDROME	0.00404858	0.14883325817374748
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.14883325817374748
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.14883325817374748
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00404858	0.14883325817374748
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.14883325817374748
FREEMAN-SHELDON SYNDROME	0.00404858	0.14883325817374748
RING CHROMOSOME 1 SYNDROME	0.00404858	0.14883325817374748
JEUNE SYNDROME	0.00404858	0.14883325817374748
PEMPHIGUS VULGARIS	0.00404858	0.14883325817374748
SCHWARTZ-JAMPEL SYNDROME	0.00404858	0.14883325817374748
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.14883325817374748
CAFFEY DISEASE	0.00404858	0.14883325817374748
CHERUBISM	0.00404858	0.14883325817374748
LEPRECHAUNISM	0.00404858	0.14883325817374748
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.14883325817374748
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.14883325817374748
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.14883325817374748
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.14883325817374748
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00404858	0.14883325817374748
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00404858	0.14883325817374748
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.14883325817374748
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.14883325817374748
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.14883325817374748
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.14883325817374748
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.14883325817374748
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.14883325817374748
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.14883325817374748
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.14883325817374748
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.14883325817374748
PIERRE ROBIN SYNDROME	0.00404858	0.14883325817374748
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003945283	0.14503587018349565
LATHOSTEROLOSIS	0.003945283	0.14503587018349565
INFANTILE SIALIC ACID STORAGE DISEASE	0.003945283	0.14503587018349565
20P12.3 MICRODELETION SYNDROME	0.003945283	0.14503587018349565
C SYNDROME	0.003945283	0.14503587018349565
TRISOMY X	0.003945283	0.14503587018349565
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.003945283	0.14503587018349565
22Q11.2 MICRODUPLICATION SYNDROME	0.003945283	0.14503587018349565
TEMPLE-BARAITSER SYNDROME; TMBTS	0.003945283	0.14503587018349565
1Q21.1 MICRODELETION SYNDROME	0.003945283	0.14503587018349565
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.003945283	0.14503587018349565
WEAVER SYNDROME	0.003945283	0.14503587018349565
SIMPSON-GOLABI-BEHMEL SYNDROME	0.003945283	0.14503587018349565
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.003945283	0.14503587018349565
MONOSOMY 9P	0.003945283	0.14503587018349565
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003941744	0.14490577002475435
HURLER SYNDROME	0.003941744	0.14490577002475435
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003941744	0.14490577002475435
GALACTOSE EPIMERASE DEFICIENCY	0.003941744	0.14490577002475435
PRIMARY CONGENITAL HYPOTHYROIDISM	0.003941744	0.14490577002475435
KABUKI SYNDROME	0.003937609	0.14475375980819732
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.003937609	0.14475375980819732
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.003937609	0.14475375980819732
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.003937609	0.14475375980819732
5Q14.3 MICRODELETION SYNDROME	0.003937609	0.14475375980819732
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.003937609	0.14475375980819732
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.003937609	0.14475375980819732
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.003937609	0.14475375980819732
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0038005199999999995	0.13971411565400477
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0038005199999999995	0.13971411565400477
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0038005199999999995	0.13971411565400477
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0038005199999999995	0.13971411565400477
COACH SYNDROME	0.003791063	0.13936645891446917
INFANTILE REFSUM DISEASE	0.003791063	0.13936645891446917
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003791063	0.13936645891446917
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.003791063	0.13936645891446917
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003791063	0.13936645891446917
MEVALONIC ACIDURIA	0.003791063	0.13936645891446917
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.003791063	0.13936645891446917
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.003791063	0.13936645891446917
HARTNUP DISEASE	0.003791063	0.13936645891446917
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.003791063	0.13936645891446917
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.003791063	0.13936645891446917
PELIZAEUS-MERZBACHER DISEASE	0.003791063	0.13936645891446917
LEIGH SYNDROME; LS	0.003791063	0.13936645891446917
TAY-SACHS DISEASE	0.003791063	0.13936645891446917
MAPLE SYRUP URINE DISEASE	0.0037910629999999995	0.13936645891446914
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0037910629999999995	0.13936645891446914
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.0037910629999999995	0.13936645891446914
ELEJALDE DISEASE	0.0037910629999999995	0.13936645891446914
XANTHINURIA, TYPE I	0.00378788	0.13924944597147013
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.13924944597147013
ZINC, ELEVATED PLASMA	0.00378788	0.13924944597147013
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.13924944597147013
DERMATOLEUKODYSTROPHY	0.00378788	0.13924944597147013
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.13924944597147013
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.13924944597147013
ALKAPTONURIA	0.00378788	0.13924944597147013
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.13924944597147013
TRISOMY 18-LIKE SYNDROME	0.00378788	0.13924944597147013
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.13924944597147013
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.13924944597147013
OSTEOMESOPYKNOSIS	0.00378788	0.13924944597147013
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.13924944597147013
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.13924944597147013
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.13924944597147013
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.13924944597147013
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.13924944597147013
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.13924944597147013
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.13924944597147013
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.13924944597147013
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.13924944597147013
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.13924944597147013
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.13924944597147013
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.13924944597147013
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.13924944597147013
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.13924944597147013
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.13924944597147013
FINGERPRINT BODY MYOPATHY	0.00378788	0.13924944597147013
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.13924944597147013
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.13924944597147013
CEPHALIN LIPIDOSIS	0.00378788	0.13924944597147013
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.13924944597147013
AREDYLD	0.00378788	0.13924944597147013
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.13924944597147013
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.13924944597147013
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.13924944597147013
CITRULLINE TRANSPORT DEFECT	0.00378788	0.13924944597147013
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.13924944597147013
DERMATITIS, ATOPIC	0.00378788	0.13924944597147013
PENDRED SYNDROME	0.00378788	0.13924944597147013
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.13924944597147013
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.13924944597147013
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.13924944597147013
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.13924944597147013
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.13924944597147013
T-SUBSTANCE ANOMALY	0.00378788	0.13924944597147013
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.13924944597147013
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.13924944597147013
OSTEOGENIC SARCOMA	0.00378788	0.13924944597147013
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.13924944597147013
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.13924944597147013
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.13924944597147013
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.13924944597147013
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.13924944597147013
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.13924944597147013
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.13924944597147013
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.13924944597147013
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.13924944597147013
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.13924944597147013
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.13924944597147013
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.13924944597147013
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.13924944597147013
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.13924944597147013
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.13924944597147013
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.13924944597147013
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.13924944597147013
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.13924944597147013
PREMATURE OVARIAN FAILURE 1	0.00378788	0.13924944597147013
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.13924944597147013
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.13924944597147013
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.13924944597147013
PYGMY	0.00378788	0.13924944597147013
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.13924944597147013
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.13924944597147013
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.13924944597147013
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.13924944597147013
PROGESTERONE RESISTANCE	0.00378788	0.13924944597147013
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.13924944597147013
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.13924944597147013
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.13924944597147013
PITUITARY DWARFISM IV	0.00378788	0.13924944597147013
LARON SYNDROME	0.00378788	0.13924944597147013
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.13924944597147013
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.13924944597147013
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.13924944597147013
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.13924944597147013
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.13924944597147013
ONCOCYTOMA	0.00378788	0.13924944597147013
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.13924944597147013
GLUTATHIONURIA	0.00378788	0.13924944597147013
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.13924944597147013
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.13924944597147013
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.13924944597147013
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.13924944597147013
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.13924944597147013
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.13924944597147013
BARTTER SYNDROME	0.00378788	0.13924944597147013
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.13924944597147013
SCHIZOPHRENIA 4	0.00378788	0.13924944597147013
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.13924944597147013
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.13924944597147013
ETHANOLAMINOSIS	0.00378788	0.13924944597147013
HOOFT DISEASE	0.00378788	0.13924944597147013
HYPOASCORBEMIA	0.00378788	0.13924944597147013
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.13924944597147013
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.13924944597147013
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.13924944597147013
XM SYSTEM	0.00378788	0.13924944597147013
DELETED IN AZOOSPERMIA	0.00378788	0.13924944597147013
GONADOBLASTOMA	0.00378788	0.13924944597147013
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.13924944597147013
LYMPHOKINE DEFICIENCY	0.00378788	0.13924944597147013
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.13924944597147013
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.13924944597147013
LIPASE DEFICIENCY, COMBINED	0.00378788	0.13924944597147013
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.13924944597147013
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.13924944597147013
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.13924944597147013
ACETYLATION, SLOW	0.00378788	0.13924944597147013
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.13924944597147013
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.13924944597147013
MACROCYTOSIS, FAMILIAL	0.00378788	0.13924944597147013
ICHTHYOSIS, X-LINKED	0.00378788	0.13924944597147013
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.13924944597147013
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.13924944597147013
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.13924944597147013
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.13924944597147013
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.13924944597147013
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.13924944597147013
FLOOD FACTOR DEFICIENCY	0.00378788	0.13924944597147013
PERRY SYNDROME	0.00378788	0.13924944597147013
MACULAR CORNEAL DYSTROPHY	0.00378788	0.13924944597147013
BEETURIA	0.00378788	0.13924944597147013
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.13924944597147013
MYOPATHY, SPHEROID BODY	0.00378788	0.13924944597147013
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.13924944597147013
CARBOXYLESTERASE 1	0.00378788	0.13924944597147013
HEINZ BODY ANEMIAS	0.00378788	0.13924944597147013
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.13924944597147013
PACMAN DYSPLASIA	0.00378788	0.13924944597147013
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.13924944597147013
PARAOXONASE 1	0.00378788	0.13924944597147013
COUMARIN RESISTANCE	0.00378788	0.13924944597147013
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.13924944597147013
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.13924944597147013
GLUTATHIONE REDUCTASE	0.00378788	0.13924944597147013
GLOMUVENOUS MALFORMATIONS	0.00378788	0.13924944597147013
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.13924944597147013
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.13924944597147013
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.13924944597147013
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.13924944597147013
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.13924944597147013
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.13924944597147013
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.13924944597147013
CALVARIAL HYPEROSTOSIS	0.00378788	0.13924944597147013
OVARIAN CANCER	0.00378788	0.13924944597147013
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.13924944597147013
ALAND ISLAND EYE DISEASE	0.00378788	0.13924944597147013
APOLIPOPROTEIN(A)	0.00378788	0.13924944597147013
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.13924944597147013
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.13924944597147013
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.13924944597147013
HYPERPROGLUCAGONEMIA	0.00378788	0.13924944597147013
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.13924944597147013
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.13924944597147013
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.13924944597147013
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.13924944597147013
JOUBERT SYNDROME 14	0.003653974	0.1343268147602766
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0036539739999999995	0.13432681476027658
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0036498389999999998	0.13417480454371958
MILLER-DIEKER SYNDROME	0.0036498389999999998	0.13417480454371958
OROFACIODIGITAL SYNDROME TYPE 1	0.0036498389999999998	0.13417480454371958
CLASSIC GALACTOSEMIA	0.0036462999999999995	0.13404470438497826
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0036462999999999995	0.13404470438497826
PANHYPOPITUITARISM	0.00357143	0.13129234527648384
RHEUMATIC FEVER	0.00357143	0.13129234527648384
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.13129234527648384
WOUND BOTULISM	0.00357143	0.13129234527648384
NK-CELL ENTEROPATHY	0.00357143	0.13129234527648384
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.13129234527648384
OCHOA SYNDROME	0.00357143	0.13129234527648384
VISCERAL MYOPATHY; VSCM	0.00357143	0.13129234527648384
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.13129234527648384
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.13129234527648384
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.13129234527648384
GRFOMA	0.00357143	0.13129234527648384
PPOMA	0.00357143	0.13129234527648384
INHALATIONAL BOTULISM	0.00357143	0.13129234527648384
PRUNE BELLY SYNDROME	0.00357143	0.13129234527648384
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.13129234527648384
SOMATOSTATINOMA	0.00357143	0.13129234527648384
GLUCAGONOMA	0.00357143	0.13129234527648384
SHEEHAN SYNDROME	0.00357143	0.13129234527648384
IATROGENIC BOTULISM	0.00357143	0.13129234527648384
PUDENDAL NEURALGIA	0.00357143	0.13129234527648384
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.13129234527648384
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.13129234527648384
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.13129234527648384
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.13129234527648384
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.13129234527648384
MALT LYMPHOMA	0.00357143	0.13129234527648384
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00357143	0.13129234527648384
UROFACIAL SYNDROME	0.00357143	0.13129234527648384
KAPUR-TORIELLO SYNDROME	0.00357143	0.13129234527648384
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.13129234527648384
BOTULISM	0.00357143	0.13129234527648384
PSEUDOMYXOMA PERITONEI	0.00357143	0.13129234527648384
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.13129234527648384
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.13129234527648384
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.13129234527648384
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.13129234527648384
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.13129234527648384
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.13129234527648384
LIDDLE SYNDROME	0.00357143	0.13129234527648384
FOODBORNE BOTULISM	0.00357143	0.13129234527648384
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.13129234527648384
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.13129234527648384
MYXEDEMA	0.00357143	0.13129234527648384
WAARDENBURG-SHAH SYNDROME	0.00357143	0.13129234527648384
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.13129234527648384
UROFACIAL SYNDROME 2	0.00357143	0.13129234527648384
ADIPOSIS DOLOROSA	0.00357143	0.13129234527648384
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.13129234527648384
HINMAN SYNDROME	0.00357143	0.13129234527648384
FG SYNDROME 2; FGS2	0.00357143	0.13129234527648384
CAP POLYPOSIS	0.00357143	0.13129234527648384
TOWNES-BROCKS SYNDROME	0.00357143	0.13129234527648384
ATTRV30M AMYLOIDOSIS	0.00357143	0.13129234527648384
PURE AUTONOMIC FAILURE	0.00357143	0.13129234527648384
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.13129234527648384
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.13129234527648384
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00357143	0.13129234527648384
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.13129234527648384
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.13129234527648384
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.13129234527648384
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.13129234527648384
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.13129234527648384
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.13129234527648384
PARATHYROID CARCINOMA	0.00357143	0.13129234527648384
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.13129234527648384
HIRSCHSPRUNG DISEASE	0.00357143	0.13129234527648384
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.13129234527648384
PORPHYRIA VARIEGATA	0.00357143	0.13129234527648384
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.13129234527648384
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.13129234527648384
14Q22Q23 MICRODELETION SYNDROME	0.0034038640000000004	0.12513231046448997
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0034038640000000004	0.12513231046448997
MONOSOMY 18P	0.0034038640000000004	0.12513231046448997
17Q21.31 MICRODUPLICATION SYNDROME	0.0034038640000000004	0.12513231046448997
CODAS SYNDROME	0.0034038640000000004	0.12513231046448997
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0034038640000000004	0.12513231046448997
LATERAL MENINGOCELE SYNDROME	0.0034038640000000004	0.12513231046448997
HADZISELIMOVIC SYNDROME	0.0034038640000000004	0.12513231046448997
DISTAL MONOSOMY 9P	0.0034038640000000004	0.12513231046448997
TRISOMY 18	0.0034038640000000004	0.12513231046448997
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0034038640000000004	0.12513231046448997
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0034038640000000004	0.12513231046448997
OROFACIODIGITAL SYNDROME VI	0.0034038640000000004	0.12513231046448997
8Q12 MICRODUPLICATION SYNDROME	0.0034038639999999995	0.12513231046448992
TETRASOMY X	0.0034038639999999995	0.12513231046448992
DISTAL MONOSOMY 3P	0.003399729	0.12498030024793293
CHROMOSOME 18Q DELETION SYNDROME	0.003399729	0.12498030024793293
WOLCOTT-RALLISON SYNDROME	0.003399729	0.12498030024793293
ZUNICH NEUROECTODERMAL SYNDROME	0.003399729	0.12498030024793293
POTOCKI-SHAFFER SYNDROME	0.003399729	0.12498030024793293
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.003399729	0.12498030024793293
INFANTILE SYSTEMIC HYALINOSIS	0.0033961899999999995	0.1248502000891916
NATIVE AMERICAN MYOPATHY	0.0033961899999999995	0.1248502000891916
STUVE-WIEDEMANN SYNDROME	0.0033961899999999995	0.1248502000891916
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0032561729999999994	0.11970291726170303
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0032561729999999994	0.11970291726170303
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0032561729999999994	0.11970291726170303
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0032561729999999994	0.11970291726170303
COFFIN-SIRIS SYNDROME 4; CSS4	0.0032561729999999994	0.11970291726170303
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0032561729999999994	0.11970291726170303
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0032561729999999994	0.11970291726170303
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0032561729999999994	0.11970291726170303
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0032561729999999994	0.11970291726170303
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0032561729999999994	0.11970291726170303
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0032561729999999994	0.11970291726170303
17Q12 MICRODELETION SYNDROME	0.0032561729999999994	0.11970291726170303
ZTTK SYNDROME; ZTTKS	0.0032561729999999994	0.11970291726170303
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0032561729999999994	0.11970291726170303
BOHRING-OPITZ SYNDROME	0.0032561729999999994	0.11970291726170303
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0032561729999999994	0.11970291726170303
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0032561729999999994	0.11970291726170303
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0032561729999999994	0.11970291726170303
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0032561729999999994	0.11970291726170303
WIEACKER-WOLFF SYNDROME	0.0032561729999999994	0.11970291726170303
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0032561729999999994	0.11970291726170303
GAUCHER DISEASE, TYPE II	0.0032561729999999994	0.11970291726170303
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0032561729999999994	0.11970291726170303
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0032561729999999994	0.11970291726170303
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0032561729999999994	0.11970291726170303
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0032561729999999994	0.11970291726170303
COFFIN-SIRIS SYNDROME 2; CSS2	0.0032561729999999994	0.11970291726170303
COFFIN-SIRIS SYNDROME 3; CSS3	0.0032561729999999994	0.11970291726170303
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0032561729999999994	0.11970291726170303
HELSMOORTEL-VAN DER AA SYNDROME	0.0032561729999999994	0.11970291726170303
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0032561729999999994	0.11970291726170303
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0032561729999999994	0.11970291726170303
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0032561729999999994	0.11970291726170303
GENITOPATELLAR SYNDROME	0.0032561729999999994	0.11970291726170303
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0032561729999999994	0.11970291726170303
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0032561729999999994	0.11970291726170303
STT3B-CDG	0.0032561729999999994	0.11970291726170303
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0032561729999999994	0.11970291726170303
STT3A-CDG	0.0032561729999999994	0.11970291726170303
KBG SYNDROME	0.0032561729999999994	0.11970291726170303
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0032561729999999994	0.11970291726170303
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0032561729999999994	0.11970291726170303
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0032561729999999994	0.11970291726170303
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0032561729999999994	0.11970291726170303
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0032561729999999994	0.11970291726170303
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0032561729999999994	0.11970291726170303
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0032561729999999994	0.11970291726170303
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0032561729999999994	0.11970291726170303
SSR4-CDG	0.0032561729999999994	0.11970291726170303
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0032561729999999994	0.11970291726170303
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0032496440000000003	0.11946289919546346
ARIMA SYNDROME	0.0032496440000000003	0.11946289919546346
JOUBERT SYNDROME 6	0.0032496440000000003	0.11946289919546346
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0032496440000000003	0.11946289919546346
JOUBERT SYNDROME 2	0.0032496440000000003	0.11946289919546346
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0032496440000000003	0.11946289919546346
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0032496440000000003	0.11946289919546346
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0032496439999999994	0.11946289919546342
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0032496439999999994	0.11946289919546342
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0032496439999999994	0.11946289919546342
JOUBERT SYNDROME 8	0.0032496439999999994	0.11946289919546342
WAARDENBURG-SHAH SYNDROME	0.0032496439999999994	0.11946289919546342
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0032496439999999994	0.11946289919546342
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0032496439999999994	0.11946289919546342
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0032496439999999994	0.11946289919546342
CAMOS SYNDROME	0.003245509	0.11931088897890643
ANGELMAN SYNDROME	0.003245509	0.11931088897890643
LEIGH SYNDROME	0.003245509	0.11931088897890643
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.003245509	0.11931088897890643
ISOLATED CEREBELLAR AGENESIS	0.003245509	0.11931088897890643
METACHROMATIC LEUKODYSTROPHY	0.0032455089999999997	0.1193108889789064
CYCLIC VOMITING SYNDROME	0.0032455089999999997	0.1193108889789064
METACHROMATIC LEUKODYSTROPHY	0.0032455089999999997	0.1193108889789064
BETA-KETOTHIOLASE DEFICIENCY	0.0032455089999999997	0.1193108889789064
DYSEQUILIBRIUM SYNDROME	0.0032455089999999997	0.1193108889789064
KALLMANN SYNDROME	0.0032455089999999997	0.1193108889789064
SIALIDOSIS TYPE 1	0.0032455089999999997	0.1193108889789064
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.0032455089999999997	0.1193108889789064
PELIZAEUS-MERZBACHER DISEASE	0.0032455089999999997	0.1193108889789064
GM1 GANGLIOSIDOSIS	0.0032455089999999997	0.1193108889789064
TRIPLE A SYNDROME	0.0032455089999999997	0.1193108889789064
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0032455089999999997	0.1193108889789064
LAURENCE-MOON SYNDROME	0.0031084199999999998	0.11427124482471386
CAREY-FINEMAN-ZITER SYNDROME	0.00285831	0.10507674052892722
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00285831	0.10507674052892722
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00285831	0.10507674052892722
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00285831	0.10507674052892722
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00285831	0.10507674052892722
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00285831	0.10507674052892722
8Q21.11 MICRODELETION SYNDROME	0.00285831	0.10507674052892722
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00285831	0.10507674052892722
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00285831	0.10507674052892722
HYPOTONIA-CYSTINURIA SYNDROME	0.00285831	0.10507674052892722
NEUROFACIODIGITORENAL SYNDROME	0.00285831	0.10507674052892722
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00285831	0.10507674052892722
MONOSOMY 13Q14	0.00285831	0.10507674052892722
DOWN SYNDROME	0.00285831	0.10507674052892722
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00285831	0.10507674052892722
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00285831	0.10507674052892722
CARTILAGE-HAIR HYPOPLASIA	0.00285831	0.10507674052892722
6P22 MICRODELETION SYNDROME	0.00285831	0.10507674052892722
POTOCKI-SHAFFER SYNDROME	0.002718293	0.09992945770143866
6Q25 MICRODELETION SYNDROME	0.002718293	0.09992945770143866
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.002718293	0.09992945770143866
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.09992945770143866
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.002718293	0.09992945770143866
MATERNAL PHENYLKETONURIA	0.002718293	0.09992945770143866
20Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.09992945770143866
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002718293	0.09992945770143866
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002718293	0.09992945770143866
SIALURIA	0.002718293	0.09992945770143866
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.002718293	0.09992945770143866
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.002718293	0.09992945770143866
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002718293	0.09992945770143866
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002718293	0.09992945770143866
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.002718293	0.09992945770143866
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.09992945770143866
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.09992945770143866
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002718293	0.09992945770143866
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.09992945770143866
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002718293	0.09992945770143866
MAN1B1-CDG	0.002718293	0.09992945770143866
15Q24 MICRODELETION SYNDROME	0.002718293	0.09992945770143866
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.09992945770143866
OCULOECTODERMAL SYNDROME; OES	0.002718293	0.09992945770143866
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.09992945770143866
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.002718293	0.09992945770143866
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.002718293	0.09992945770143866
AL KAISSI SYNDROME; ALKAS	0.002718293	0.09992945770143866
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.09992945770143866
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.09992945770143866
DISTAL MONOSOMY 1Q	0.0027182929999999997	0.09992945770143863
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0027182929999999997	0.09992945770143863
XQ25 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.09992945770143863
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027182929999999997	0.09992945770143863
XQ25 DUPLICATION SYNDROME	0.0027182929999999997	0.09992945770143863
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0027182929999999997	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0027182929999999997	0.09992945770143863
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0027147539999999998	0.09979935754269734
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.09979935754269734
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.09979935754269734
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.09979935754269734
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.09979935754269734
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0027147539999999998	0.09979935754269734
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.09979935754269734
TYSHCHENKO SYNDROME	0.0027147539999999998	0.09979935754269734
EAR-PATELLA-SHORT STATURE SYNDROME	0.0027147539999999998	0.09979935754269734
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.09979935754269734
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.09979935754269734
POPOV-CHANG SYNDROME; POPCHAS	0.0027147539999999998	0.09979935754269734
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0027147539999999998	0.09979935754269734
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0027147539999999998	0.09979935754269734
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.09979935754269734
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.09979935754269734
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.09979935754269734
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.09979935754269734
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0027147539999999998	0.09979935754269734
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0027147539999999998	0.09979935754269734
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.09979935754269734
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.09979935754269734
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.09979935754269734
AURICULOCONDYLAR SYNDROME	0.0027147539999999998	0.09979935754269734
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0027147539999999998	0.09979935754269734
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0027147539999999998	0.09979935754269734
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0027147539999999998	0.09979935754269734
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.0996473473261403
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.0996473473261403
CRISPONI SYNDROME	0.0027106189999999996	0.0996473473261403
17Q24.2 MICRODELETION SYNDROME	0.0027106189999999996	0.0996473473261403
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.0996473473261403
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.0996473473261403
16Q24.3 MICRODELETION SYNDROME	0.0027106189999999996	0.0996473473261403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.0996473473261403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0027106189999999996	0.0996473473261403
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0027106189999999996	0.0996473473261403
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.0996473473261403
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.0996473473261403
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.0996473473261403
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.0996473473261403
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.0996473473261403
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0027106189999999996	0.0996473473261403
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0027106189999999996	0.0996473473261403
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.0996473473261403
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00270409	0.09940732925990069
MUCOLIPIDOSIS TYPE IV	0.00270409	0.09940732925990069
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00270409	0.09940732925990069
CEREBELLAR HYPOPLASIA	0.00270409	0.09940732925990069
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00270409	0.09940732925990069
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00270409	0.09940732925990069
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00270409	0.09940732925990069
PIEBALDISM	0.00270409	0.09940732925990069
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00270409	0.09940732925990069
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00270409	0.09940732925990069
KEARNS-SAYRE SYNDROME	0.00270409	0.09940732925990069
ABETALIPOPROTEINEMIA	0.00270409	0.09940732925990069
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00270409	0.09940732925990069
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00270409	0.09940732925990069
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00270409	0.09940732925990069
JOUBERT SYNDROME 5	0.00270409	0.09940732925990069
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00270409	0.09940732925990069
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00270409	0.09940732925990069
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00270409	0.09940732925990069
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00270409	0.09940732925990069
CHÉDIAK-HIGASHI SYNDROME	0.002564073	0.09426004643241215
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002564073	0.09426004643241215
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.002564073	0.09426004643241215
SRD5A3-CDG	0.002564073	0.09426004643241215
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002564073	0.09426004643241215
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002564073	0.09426004643241215
COWDEN SYNDROME	0.002564073	0.09426004643241215
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002564073	0.09426004643241215
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.002564073	0.09426004643241215
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002564073	0.09426004643241215
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.002564073	0.09426004643241215
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.002564073	0.09426004643241215
CHROMOSOME 1P35 DELETION SYNDROME	0.002564073	0.09426004643241215
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.002564073	0.09426004643241215
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002564073	0.09426004643241215
CEDNIK SYNDROME	0.002564073	0.09426004643241215
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002564073	0.09426004643241215
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.002564073	0.09426004643241215
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002564073	0.09426004643241215
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.002564073	0.09426004643241215
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002564073	0.09426004643241215
MYHRE SYNDROME	0.002564073	0.09426004643241215
SIALIDOSIS TYPE 2	0.002564073	0.09426004643241215
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.002564073	0.09426004643241215
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002564073	0.09426004643241215
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.002564073	0.09426004643241215
CITRULLINEMIA, CLASSIC	0.002564073	0.09426004643241215
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0025640729999999996	0.09426004643241213
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0025640729999999996	0.09426004643241213
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0025640729999999996	0.09426004643241213
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0025640729999999996	0.09426004643241213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0025640729999999996	0.09426004643241213
SULFOCYSTEINURIA	0.0025640729999999996	0.09426004643241213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0025640729999999996	0.09426004643241213
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0025640729999999996	0.09426004643241213
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.0025640729999999996	0.09426004643241213
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0025640729999999996	0.09426004643241213
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0025640729999999996	0.09426004643241213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0025640729999999996	0.09426004643241213
CENTRAL BILATERAL MACROGYRIA	0.0025640729999999996	0.09426004643241213
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0025640729999999996	0.09426004643241213
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.0025640729999999996	0.09426004643241213
EAST SYNDROME	0.0025640729999999996	0.09426004643241213
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.0025640729999999996	0.09426004643241213
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0025640729999999996	0.09426004643241213
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0025640729999999996	0.09426004643241213
NIEMANN-PICK DISEASE TYPE C	0.0025640729999999996	0.09426004643241213
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0025640729999999996	0.09426004643241213
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0025640729999999996	0.09426004643241213
FUCOSIDOSIS	0.002313963	0.08506554213662548
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.002313963	0.08506554213662548
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002313963	0.08506554213662548
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002313963	0.08506554213662548
ISOLATED GLYCEROL KINASE DEFICIENCY	0.002313963	0.08506554213662548
GALLOWAY-MOWAT SYNDROME	0.002313963	0.08506554213662548
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.002313963	0.08506554213662548
FILIPPI SYNDROME	0.002313963	0.08506554213662548
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002313963	0.08506554213662548
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002313963	0.08506554213662548
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002313963	0.08506554213662548
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.002313963	0.08506554213662548
CODAS SYNDROME	0.002313963	0.08506554213662548
3Q29 MICRODUPLICATION SYNDROME	0.002313963	0.08506554213662548
LEBER CONGENITAL AMAUROSIS	0.002313963	0.08506554213662548
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002313963	0.08506554213662548
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002313963	0.08506554213662548
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002313963	0.08506554213662548
2Q37 MICRODELETION SYNDROME	0.002313963	0.08506554213662548
GRISCELLI SYNDROME, TYPE 1	0.002313963	0.08506554213662548
KLEEFSTRA SYNDROME 2; KLEFS2	0.002313963	0.08506554213662548
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.002313963	0.08506554213662548
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.002313963	0.08506554213662548
ALG3-CDG	0.002313963	0.08506554213662548
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.002313963	0.08506554213662548
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002313963	0.08506554213662548
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.002313963	0.08506554213662548
RECOMBINANT CHROMOSOME 8 SYNDROME	0.002313963	0.08506554213662548
WALKER-WARBURG SYNDROME	0.002313963	0.08506554213662548
1Q21.1 MICRODUPLICATION SYNDROME	0.002313963	0.08506554213662548
DPAGT1-CDG	0.002313963	0.08506554213662548
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002313963	0.08506554213662548
CONGENITAL TOXOPLASMOSIS	0.002313963	0.08506554213662548
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.002313963	0.08506554213662548
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.002313963	0.08506554213662548
MICRO SYNDROME	0.002313963	0.08506554213662548
2P21 MICRODELETION SYNDROME	0.002313963	0.08506554213662548
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.002313963	0.08506554213662548
INCONTINENTIA PIGMENTI	0.002313963	0.08506554213662548
VICI SYNDROME; VICIS	0.002313963	0.08506554213662548
MULTIPLE CARBOXYLASE DEFICIENCY	0.002313963	0.08506554213662548
SCHINDLER DISEASE, TYPE I	0.002313963	0.08506554213662548
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.002313963	0.08506554213662548
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.002313963	0.08506554213662548
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002313963	0.08506554213662548
KETOADIPICACIDURIA	0.002313963	0.08506554213662548
ADAMS-OLIVER SYNDROME 1; AOS1	0.002313963	0.08506554213662548
PYRUVATE CARBOXYLASE DEFICIENCY	0.002313963	0.08506554213662548
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.002313963	0.08506554213662548
SEVERE CANAVAN DISEASE	0.002313963	0.08506554213662548
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.08002589798243293
LIG4 SYNDROME	0.0021768739999999996	0.08002589798243293
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021768739999999996	0.08002589798243293
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.08002589798243293
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.08002589798243293
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.08002589798243293
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.08002589798243293
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0021768739999999996	0.08002589798243293
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.08002589798243293
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.08002589798243293
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.08002589798243293
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.08002589798243293
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.08002589798243293
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.08002589798243293
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0021768739999999996	0.08002589798243293
BARATELA-SCOTT SYNDROME	0.0021768739999999996	0.08002589798243293
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.08002589798243293
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.08002589798243293
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.08002589798243293
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.08002589798243293
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.08002589798243293
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.08002589798243293
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.08002589798243293
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.08002589798243293
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.08002589798243293
OGDEN SYNDROME; OGDNS	0.0021768739999999996	0.08002589798243293
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.08002589798243293
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.08002589798243293
MONOSOMY 13Q34	0.0021768739999999996	0.08002589798243293
DISTAL MONOSOMY 6P	0.0021768739999999996	0.08002589798243293
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.08002589798243293
FANCONI ANEMIA	0.0021768739999999996	0.08002589798243293
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0021768739999999996	0.08002589798243293
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.08002589798243293
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.08002589798243293
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.08002589798243293
ICF SYNDROME	0.0021768739999999996	0.08002589798243293
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0021768739999999996	0.08002589798243293
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.08002589798243293
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.08002589798243293
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0021768739999999996	0.08002589798243293
VASCULAR EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.08002589798243293
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.08002589798243293
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.08002589798243293
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0021768739999999996	0.08002589798243293
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021768739999999996	0.08002589798243293
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.08002589798243293
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.08002589798243293
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.08002589798243293
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0021768739999999996	0.08002589798243293
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.08002589798243293
TRISOMY 12P	0.0021768739999999996	0.08002589798243293
PHENOBARBITAL EMBRYOPATHY	0.0021768739999999996	0.08002589798243293
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.08002589798243293
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.08002589798243293
FETAL TRIMETHADIONE SYNDROME	0.0021768739999999996	0.08002589798243293
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.08002589798243293
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.08002589798243293
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.002172739	0.07987388776587591
TETRASOMY 18P	0.002172739	0.07987388776587591
CHIME SYNDROME	0.002172739	0.07987388776587591
MOMO SYNDROME	0.002172739	0.07987388776587591
FOUNTAIN SYNDROME	0.002172739	0.07987388776587591
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.07987388776587591
KNOBLOCH SYNDROME	0.002172739	0.07987388776587591
OROFACIODIGITAL SYNDROME I; OFD1	0.002172739	0.07987388776587591
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002172739	0.07987388776587591
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.07987388776587591
DUBOWITZ SYNDROME	0.002172739	0.07987388776587591
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.002172739	0.07987388776587591
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.07987388776587591
SAETHRE-CHOTZEN SYNDROME	0.002172739	0.07987388776587591
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.002172739	0.07987388776587591
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.07987388776587591
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002172739	0.07987388776587591
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002172739	0.07987388776587591
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.07987388776587591
HENNEKAM SYNDROME	0.002172739	0.07987388776587591
RENPENNING SYNDROME	0.002172739	0.07987388776587591
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.07987388776587591
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.002172739	0.07987388776587591
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.07987388776587591
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.07974378760713458
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.07974378760713458
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.07974378760713458
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.07974378760713458
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.07974378760713458
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.07974378760713458
FONTAINE PROGEROID SYNDROME; FPS	0.0021691999999999996	0.07974378760713458
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.07974378760713458
BETA-THALASSEMIA MAJOR	0.0021691999999999996	0.07974378760713458
LOCKED-IN SYNDROME	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.07974378760713458
CRISS-CROSS HEART	0.0021691999999999996	0.07974378760713458
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0021691999999999996	0.07974378760713458
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.07974378760713458
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.07974378760713458
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.07974378760713458
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.07974378760713458
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.07974378760713458
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.07974378760713458
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.07974378760713458
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.07974378760713458
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.07974378760713458
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.07974378760713458
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.07974378760713458
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.07974378760713458
CHOANAL ATRESIA	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.07974378760713458
SANDIFER SYNDROME	0.0021691999999999996	0.07974378760713458
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.07974378760713458
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.07974378760713458
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.07974378760713458
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.07974378760713458
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.07974378760713458
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.07974378760713458
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.07974378760713458
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.07974378760713458
CHARGE SYNDROME	0.0021691999999999996	0.07974378760713458
MEIER-GORLIN SYNDROME 6; MGORS6	0.0021691999999999996	0.07974378760713458
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.07974378760713458
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.07974378760713458
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.07974378760713458
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.07974378760713458
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.07974378760713458
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.07974378760713458
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.07974378760713458
MEIER-GORLIN SYNDROME 3; MGORS3	0.0021691999999999996	0.07974378760713458
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.07974378760713458
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.07974378760713458
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713458
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07435648671340642
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.0020226539999999996	0.07435648671340642
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07435648671340642
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07435648671340642
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 21	0.0020226539999999996	0.07435648671340642
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07435648671340642
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0020226539999999996	0.07435648671340642
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0020226539999999996	0.07435648671340642
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07435648671340642
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 7	0.0020226539999999996	0.07435648671340642
IMMUNODEFICIENCY 23; IMD23	0.0020226539999999996	0.07435648671340642
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 27	0.0020226539999999996	0.07435648671340642
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 28	0.0020226539999999996	0.07435648671340642
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0020226539999999996	0.07435648671340642
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07435648671340642
BARDET-BIEDL SYNDROME 1; BBS1	0.0020226539999999996	0.07435648671340642
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07435648671340642
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07435648671340642
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07435648671340642
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0020226539999999996	0.07435648671340642
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0020226539999999996	0.07435648671340642
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 15	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07435648671340642
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0020226539999999996	0.07435648671340642
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07435648671340642
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 25	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07435648671340642
PEROXISOME BIOGENESIS DISORDER 6B	0.0020226539999999996	0.07435648671340642
SENIOR-LOKEN SYNDROME	0.0020226539999999996	0.07435648671340642
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07435648671340642
NAVAJO NEUROHEPATOPATHY	0.0020226539999999996	0.07435648671340642
HOYERAAL-HREIDARSSON SYNDROME	0.0020226539999999996	0.07435648671340642
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0020226539999999996	0.07435648671340642
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0020226539999999996	0.07435648671340642
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07435648671340642
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07435648671340642
FLYNN-AIRD SYNDROME	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.07420447649684939
LISSENCEPHALY 3; LIS3	0.002018519	0.07420447649684939
ALEXANDER DISEASE	0.002018519	0.07420447649684939
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07420447649684939
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07420447649684939
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.07420447649684939
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07420447649684939
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.002018519	0.07420447649684939
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.002018519	0.07420447649684939
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.002018519	0.07420447649684939
RETT SYNDROME	0.002018519	0.07420447649684939
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07420447649684939
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07420447649684939
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002018519	0.07420447649684939
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.07420447649684939
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.07420447649684939
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002018519	0.07420447649684939
XERODERMA PIGMENTOSUM	0.002018519	0.07420447649684939
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.07420447649684939
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.002018519	0.07420447649684939
SANDHOFF DISEASE	0.002018519	0.07420447649684939
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.07420447649684939
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.002018519	0.07420447649684939
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.002018519	0.07420447649684939
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.002018519	0.07420447649684939
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002018519	0.07420447649684939
KUFOR-RAKEB SYNDROME	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.07420447649684939
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.07420447649684939
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07420447649684939
TYROSINEMIA TYPE 2	0.002018519	0.07420447649684939
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07420447649684939
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.07420447649684939
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07420447649684939
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.07420447649684939
COCKAYNE SYNDROME A; CSA	0.002018519	0.07420447649684939
ATAXIA-TELANGIECTASIA	0.002018519	0.07420447649684939
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.07420447649684939
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.07420447649684939
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.07420447649684939
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07420447649684939
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07420447649684939
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.07420447649684939
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.07420447649684939
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07420447649684939
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.002018519	0.07420447649684939
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07420447649684939
THYROCEREBRORETINAL SYNDROME	0.002018519	0.07420447649684939
HEREDITARY HYPEREKPLEXIA	0.002018519	0.07420447649684939
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.07420447649684939
MUCOPOLYSACCHARIDOSIS TYPE 3	0.002018519	0.07420447649684939
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07420447649684939
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.07420447649684939
BEHÇET DISEASE	0.002018519	0.07420447649684939
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.002018519	0.07420447649684939
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.07420447649684939
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002018519	0.07420447649684939
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07420447649684939
FLYNN-AIRD SYNDROME	0.002018519	0.07420447649684939
EPISODIC ATAXIA TYPE 6	0.002018519	0.07420447649684939
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07420447649684939
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.07420447649684939
WHIPPLE DISEASE	0.002018519	0.07420447649684939
DILATED CARDIOMYOPATHY WITH ATAXIA	0.002018519	0.07420447649684939
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.07420447649684939
MEGALENCEPHALY WITH DYSMYELINATION	0.002018519	0.07420447649684939
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07420447649684939
DIAMINOPENTANURIA	0.002018519	0.07420447649684939
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.002018519	0.07420447649684939
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.07420447649684939
ROIFMAN SYNDROME; RFMN	0.001772544	0.06516198241761977
CRANIOSYNOSTOSIS 6; CRS6	0.001772544	0.06516198241761977
17P11.2 MICRODUPLICATION SYNDROME	0.001772544	0.06516198241761977
20Q11.2 MICRODELETION SYNDROME	0.001772544	0.06516198241761977
GENITOPATELLAR SYNDROME; GTPTS	0.001772544	0.06516198241761977
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001772544	0.06516198241761977
PEROXISOME BIOGENESIS DISORDER 3B	0.001772544	0.06516198241761977
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001772544	0.06516198241761977
17P13.3 MICRODUPLICATION SYNDROME	0.001772544	0.06516198241761977
COLE-CARPENTER SYNDROME	0.001772544	0.06516198241761977
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001772544	0.06516198241761977
GERODERMA OSTEODYSPLASTICA	0.001772544	0.06516198241761977
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001772544	0.06516198241761977
GERMAN SYNDROME	0.001772544	0.06516198241761977
12Q14 MICRODELETION SYNDROME	0.001772544	0.06516198241761977
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.001772544	0.06516198241761977
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001772544	0.06516198241761977
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001772544	0.06516198241761977
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001772544	0.06516198241761977
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001772544	0.06516198241761977
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06516198241761977
XQ27.3Q28 DUPLICATION SYNDROME	0.001772544	0.06516198241761977
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001772544	0.06516198241761977
CRANIOFRONTONASAL SYNDROME; CFNS	0.001772544	0.06516198241761977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001772544	0.06516198241761977
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001772544	0.06516198241761977
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.001772544	0.06516198241761977
FRIED SYNDROME	0.001772544	0.06516198241761977
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06516198241761977
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001772544	0.06516198241761977
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.001772544	0.06516198241761977
RITSCHER-SCHINZEL SYNDROME 1	0.001772544	0.06516198241761977
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001772544	0.06516198241761977
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001772544	0.06516198241761977
ALG6-CDG	0.001772544	0.06516198241761977
PENTASOMY X	0.001772544	0.06516198241761977
ALPHA-MANNOSIDOSIS	0.001772544	0.06516198241761977
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001772544	0.06516198241761977
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001772544	0.06516198241761977
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001772544	0.06516198241761977
MICROPHTHALMIA, SYNDROMIC 3	0.001772544	0.06516198241761977
GALACTOSE EPIMERASE DEFICIENCY	0.001772544	0.06516198241761977
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001772544	0.06516198241761977
MUCOLIPIDOSIS IV; ML4	0.001772544	0.06516198241761977
THANATOPHORIC DYSPLASIA, TYPE I	0.001772544	0.06516198241761977
TRANSKETOLASE DEFICIENCY	0.001772544	0.06516198241761977
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001772544	0.06516198241761977
HYPERLYSINEMIA, TYPE I	0.001768409	0.06500997220106274
HADDAD SYNDROME	0.001768409	0.06500997220106274
MPDU1-CDG	0.001768409	0.06500997220106274
GLYCINE ENCEPHALOPATHY; GCE	0.001768409	0.06500997220106274
INFANTILE NEUROAXONAL DYSTROPHY	0.001768409	0.06500997220106274
L-2-HYDROXYGLUTARIC ACIDURIA	0.001768409	0.06500997220106274
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001768409	0.06500997220106274
ONDINE SYNDROME	0.001768409	0.06500997220106274
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001768409	0.06500997220106274
KRABBE DISEASE	0.001768409	0.06500997220106274
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.001768409	0.06500997220106274
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001768409	0.06500997220106274
LINEAR NEVUS SEBACEUS SYNDROME	0.001768409	0.06500997220106274
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.001768409	0.06500997220106274
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.001768409	0.06500997220106274
CONGENITAL RUBELLA SYNDROME	0.001768409	0.06500997220106274
1P36 MICRODELETION SYNDROME	0.001768409	0.06500997220106274
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001768409	0.06500997220106274
ALG9-CDG	0.001768409	0.06500997220106274
ZIMMERMANN-LABAND SYNDROME 1	0.001768409	0.06500997220106274
GLUTARIC ACIDEMIA I; GA1	0.001768409	0.06500997220106274
MUSCLE-EYE-BRAIN DISEASE	0.001768409	0.06500997220106274
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.001768409	0.06500997220106274
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.001768409	0.06500997220106274
BENIGN FAMILIAL INFANTILE EPILEPSY	0.001768409	0.06500997220106274
SJÖGREN-LARSSON SYNDROME	0.001768409	0.06500997220106274
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06500997220106274
ISOLATED SPINA BIFIDA	0.001768409	0.06500997220106274
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.001768409	0.06500997220106274
THANATOPHORIC DYSPLASIA	0.001768409	0.06500997220106274
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.001768409	0.06500997220106274
NORRIE DISEASE	0.001768409	0.06500997220106274
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.001768409	0.06500997220106274
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001768409	0.06500997220106274
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.001768409	0.06500997220106274
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06500997220106274
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06500997220106274
FRAGILE X SYNDROME	0.001768409	0.06500997220106274
FETAL GAUCHER DISEASE	0.001768409	0.06500997220106274
VISCERAL STEATOSIS, CONGENITAL	0.001768409	0.06500997220106274
CENTRONUCLEAR MYOPATHY	0.001768409	0.06500997220106274
WOLF-HIRSCHHORN SYNDROME	0.001768409	0.06500997220106274
DISTAL MONOSOMY 7Q36	0.001768409	0.06500997220106274
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.001768409	0.06500997220106274
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001768409	0.06500997220106274
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06500997220106274
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.001768409	0.06500997220106274
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001768409	0.06500997220106274
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.001768409	0.06500997220106274
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.001768409	0.06500997220106274
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.001768409	0.06500997220106274
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06500997220106274
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06500997220106274
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06500997220106274
THANATOPHORIC DYSPLASIA TYPE 1	0.001768409	0.06500997220106274
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.05997032804687018
OMODYSPLASIA 1; OMOD1	0.00163132	0.05997032804687018
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.05997032804687018
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.05997032804687018
SCARF SYNDROME	0.00163132	0.05997032804687018
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.05997032804687018
PTERYGIUM COLLI, ISOLATED	0.00163132	0.05997032804687018
SCARF SYNDROME	0.00163132	0.05997032804687018
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.05997032804687018
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.05997032804687018
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.05997032804687018
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.05997032804687018
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.05997032804687018
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00163132	0.05997032804687018
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.05997032804687018
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.05997032804687018
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.05997032804687018
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.05997032804687018
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.05997032804687018
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.05997032804687018
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00163132	0.05997032804687018
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.05997032804687018
SILLENCE SYNDROME	0.00163132	0.05997032804687018
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.05997032804687018
ACRORENAL-MANDIBULAR SYNDROME	0.00163132	0.05997032804687018
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.05997032804687018
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.05997032804687018
NOONAN SYNDROME 4; NS4	0.00163132	0.05997032804687018
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00163132	0.05997032804687018
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00163132	0.05997032804687018
MILROY DISEASE	0.00163132	0.05997032804687018
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.05997032804687018
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.05997032804687018
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.05997032804687018
RING CHROMOSOME 6 SYNDROME	0.00163132	0.05997032804687018
CRANIOECTODERMAL DYSPLASIA 1	0.00163132	0.05997032804687018
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.05997032804687018
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00163132	0.05997032804687018
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.05997032804687018
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.05997032804687018
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.05997032804687018
SCHOLTE SYNDROME; SHLTS	0.00163132	0.05997032804687018
BRITTLE CORNEA SYNDROME	0.00163132	0.05997032804687018
BRADDOCK SYNDROME	0.00163132	0.05997032804687018
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.05997032804687018
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.05997032804687018
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.05997032804687018
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.05997032804687018
BALLER-GEROLD SYNDROME	0.00163132	0.05997032804687018
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.05997032804687018
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.05997032804687018
ATELOSTEOGENESIS TYPE II	0.00163132	0.05997032804687018
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.05997032804687018
ACROOTOOCULAR SYNDROME	0.00163132	0.05997032804687018
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.05997032804687018
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.05997032804687018
RING CHROMOSOME 8 SYNDROME	0.00163132	0.05997032804687018
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.05997032804687018
PENOSCROTAL TRANSPOSITION	0.00163132	0.05997032804687018
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.05997032804687018
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.05997032804687018
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.05997032804687018
LEGIUS SYNDROME	0.00163132	0.05997032804687018
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.05997032804687018
NOONAN SYNDROME 8; NS8	0.00163132	0.05997032804687018
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.05997032804687018
LICHTENSTEIN SYNDROME	0.00163132	0.05997032804687018
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.05997032804687018
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.05997032804687018
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.05997032804687018
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.05997032804687018
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00163132	0.05997032804687018
PHAVER SYNDROME	0.00163132	0.05997032804687018
CEREBROOCULONASAL SYNDROME	0.00163132	0.05997032804687018
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.05997032804687018
SUMMITT SYNDROME	0.00163132	0.05997032804687018
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.05997032804687018
RENAL AGENESIS, BILATERAL	0.00163132	0.05997032804687018
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.05997032804687018
EPICANTHUS	0.00163132	0.05997032804687018
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.05997032804687018
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.05997032804687018
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.05997032804687018
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.05997032804687018
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.05997032804687018
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.05997032804687018
RING CHROMOSOME 13 SYNDROME	0.00163132	0.05997032804687018
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.05997032804687018
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.05997032804687018
MONOSOMY 22	0.00163132	0.05997032804687018
DISTAL TRISOMY 5Q	0.00163132	0.05997032804687018
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.05997032804687018
JACOBSEN SYNDROME	0.00163132	0.05997032804687018
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.05997032804687018
KEIPERT SYNDROME	0.00163132	0.05997032804687018
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.05997032804687018
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.05997032804687018
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.05997032804687018
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.05997032804687018
MYOTONIA PERMANENS	0.00163132	0.05997032804687018
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.05997032804687018
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.05997032804687018
VELO-FACIAL-SKELETAL SYNDROME	0.00163132	0.05997032804687018
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.05997032804687018
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.05997032804687018
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.05997032804687018
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.05997032804687018
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.05997032804687018
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00163132	0.05997032804687018
DIAMOND-BLACKFAN ANEMIA 1	0.00163132	0.05997032804687018
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.05997032804687018
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00163132	0.05997032804687018
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.05997032804687018
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.05997032804687018
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.05997032804687018
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00163132	0.05997032804687018
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.05997032804687018
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.05997032804687018
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.05997032804687018
OROFACIAL CLEFT 15	0.00163132	0.05997032804687018
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.05997032804687018
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.05997032804687018
JUBERG-MARSIDI SYNDROME	0.00163132	0.05997032804687018
FETAL VALPROATE SYNDROME	0.00163132	0.05997032804687018
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.05997032804687018
CEREBROOCULONASAL SYNDROME	0.00163132	0.05997032804687018
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.05997032804687018
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00163132	0.05997032804687018
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.05997032804687018
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.05997032804687018
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.05997032804687018
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.05997032804687018
FEINGOLD SYNDROME 1; FGLDS1	0.00163132	0.05997032804687018
FRONTORHINY	0.00163132	0.05997032804687018
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.05997032804687018
ACRODYSOSTOSIS	0.00163132	0.05997032804687018
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.05997032804687018
ERDHEIM-CHESTER DISEASE	0.0014770999999999999	0.054300916777843676
STIMMLER SYNDROME	0.0014770999999999999	0.054300916777843676
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.054300916777843676
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.054300916777843676
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.054300916777843676
KIKUCHI-FUJIMOTO DISEASE	0.0014770999999999999	0.054300916777843676
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.054300916777843676
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.054300916777843676
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0014770999999999999	0.054300916777843676
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.054300916777843676
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.054300916777843676
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.054300916777843676
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.054300916777843676
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.054300916777843676
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.0014770999999999999	0.054300916777843676
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0014770999999999999	0.054300916777843676
PITUITARY CARCINOMA	0.0014770999999999999	0.054300916777843676
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.054300916777843676
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.054300916777843676
GEMIGNANI SYNDROME	0.0014770999999999999	0.054300916777843676
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.054300916777843676
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.054300916777843676
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.054300916777843676
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.054300916777843676
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0014770999999999999	0.054300916777843676
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.054300916777843676
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.054300916777843676
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.054300916777843676
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.054300916777843676
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.054300916777843676
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.054300916777843676
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.054300916777843676
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.054300916777843676
CLASSIC HODGKIN LYMPHOMA	0.0014770999999999999	0.054300916777843676
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0014770999999999999	0.054300916777843676
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.054300916777843676
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.054300916777843676
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.054300916777843676
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.054300916777843676
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.054300916777843676
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.054300916777843676
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0014770999999999999	0.054300916777843676
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.054300916777843676
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.054300916777843676
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.054300916777843676
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.054300916777843676
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.054300916777843676
CHANARIN-DORFMAN SYNDROME	0.0014770999999999999	0.054300916777843676
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0014770999999999999	0.054300916777843676
REFSUM DISEASE	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.054300916777843676
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.054300916777843676
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.054300916777843676
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.054300916777843676
CHAND SYNDROME	0.0014770999999999999	0.054300916777843676
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.054300916777843676
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0014770999999999999	0.054300916777843676
ACERULOPLASMINEMIA	0.0014770999999999999	0.054300916777843676
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.054300916777843676
SANDHOFF DISEASE	0.0014770999999999999	0.054300916777843676
WALDENSTRÖM MACROGLOBULINEMIA	0.0014770999999999999	0.054300916777843676
LEGIONELLOSIS	0.0014770999999999999	0.054300916777843676
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.054300916777843676
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.054300916777843676
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0014770999999999999	0.054300916777843676
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.054300916777843676
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.054300916777843676
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.054300916777843676
VON HIPPEL-LINDAU DISEASE	0.0014770999999999999	0.054300916777843676
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.054300916777843676
USHER SYNDROME	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.054300916777843676
ACERULOPLASMINEMIA	0.0014770999999999999	0.054300916777843676
AGEL AMYLOIDOSIS	0.0014770999999999999	0.054300916777843676
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.054300916777843676
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.054300916777843676
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.054300916777843676
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0014770999999999999	0.054300916777843676
HEREDITARY SPHEROCYTOSIS	0.0014770999999999999	0.054300916777843676
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.054300916777843676
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.054300916777843676
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.054300916777843676
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.054300916777843676
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.054300916777843676
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.054300916777843676
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.054300916777843676
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.054300916777843676
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.054300916777843676
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.054300916777843676
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.054300916777843676
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.054300916777843676
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.054300916777843676
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.054300916777843676
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.054300916777843676
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.054300916777843676
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.054300916777843676
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0014770999999999999	0.054300916777843676
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.054300916777843676
RAVINE SYNDROME	0.0014770999999999999	0.054300916777843676
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.054300916777843676
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.054300916777843676
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.054300916777843676
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.054300916777843676
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.054300916777843676
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.054300916777843676
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.054300916777843676
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.054300916777843676
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0014770999999999999	0.054300916777843676
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.054300916777843676
HODGKIN LYMPHOMA	0.0014770999999999999	0.054300916777843676
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.054300916777843676
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.054300916777843676
JOUBERT SYNDROME 4	0.0014770999999999999	0.054300916777843676
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.054300916777843676
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.054300916777843676
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.054300916777843676
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.054300916777843676
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.054300916777843676
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.054300916777843676
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.054300916777843676
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.054300916777843676
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.054300916777843676
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.054300916777843676
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.054300916777843676
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.054300916777843676
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.054300916777843676
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.054300916777843676
RHOMBENCEPHALOSYNAPSIS	0.0014770999999999999	0.054300916777843676
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.054300916777843676
PENDRED SYNDROME	0.0014770999999999999	0.054300916777843676
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.054300916777843676
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.054300916777843676
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.054300916777843676
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.054300916777843676
USHER SYNDROME TYPE 3	0.0014770999999999999	0.054300916777843676
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.054300916777843676
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.054300916777843676
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.054300916777843676
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.054300916777843676
USHER SYNDROME TYPE 2	0.0014770999999999999	0.054300916777843676
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.054300916777843676
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.054300916777843676
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0014770999999999999	0.054300916777843676
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0014770999999999999	0.054300916777843676
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0014770999999999999	0.054300916777843676
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.054300916777843676
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00122699	0.04510641248205702
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.04510641248205702
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00122699	0.04510641248205702
FETAL METHYLMERCURY SYNDROME	0.00122699	0.04510641248205702
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00122699	0.04510641248205702
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.04510641248205702
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00122699	0.04510641248205702
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00122699	0.04510641248205702
JOHANSON-BLIZZARD SYNDROME; JBS	0.00122699	0.04510641248205702
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00122699	0.04510641248205702
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00122699	0.04510641248205702
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.04510641248205702
LAMBERT SYNDROME	0.00122699	0.04510641248205702
GLYCOGEN STORAGE DISEASE II	0.00122699	0.04510641248205702
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.04510641248205702
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00122699	0.04510641248205702
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00122699	0.04510641248205702
ERMINE PHENOTYPE	0.00122699	0.04510641248205702
9Q SUBTELOMERIC DELETION SYNDROME	0.00122699	0.04510641248205702
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.04510641248205702
SMITH-MAGENIS SYNDROME	0.00122699	0.04510641248205702
MENTAL RETARDATION, X-LINKED 93	0.00122699	0.04510641248205702
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.04510641248205702
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00122699	0.04510641248205702
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00122699	0.04510641248205702
CAMPOMELIC DYSPLASIA	0.00122699	0.04510641248205702
CENTRAL CORE DISEASE	0.00122699	0.04510641248205702
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.04510641248205702
LESCH-NYHAN SYNDROME; LNS	0.00122699	0.04510641248205702
CAT-EYE SYNDROME	0.00122699	0.04510641248205702
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00122699	0.04510641248205702
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.04510641248205702
DIASTROPHIC DWARFISM	0.00122699	0.04510641248205702
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00122699	0.04510641248205702
SPONASTRIME DYSPLASIA	0.00122699	0.04510641248205702
CRANIOFRONTONASAL DYSPLASIA	0.00122699	0.04510641248205702
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00122699	0.04510641248205702
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.04510641248205702
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.04510641248205702
ACID PHOSPHATASE DEFICIENCY	0.00122699	0.04510641248205702
GLYCOGEN STORAGE DISEASE IV	0.00122699	0.04510641248205702
DESBUQUOIS DYSPLASIA 1	0.00122699	0.04510641248205702
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00122699	0.04510641248205702
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00122699	0.04510641248205702
ANTISYNTHETASE SYNDROME	0.00122699	0.04510641248205702
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00122699	0.04510641248205702
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00122699	0.04510641248205702
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00122699	0.04510641248205702
COG7-CDG	0.00122699	0.04510641248205702
B4GALT1-CDG	0.00122699	0.04510641248205702
OPSISMODYSPLASIA; OPSMD	0.00122699	0.04510641248205702
ALG12-CDG	0.00122699	0.04510641248205702
COOPER-JABS SYNDROME	0.00122699	0.04510641248205702
ACHONDROPLASIA	0.00122699	0.04510641248205702
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00122699	0.04510641248205702
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00122699	0.04510641248205702
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00122699	0.04510641248205702
SENGERS SYNDROME	0.00122699	0.04510641248205702
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00122699	0.04510641248205702
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00122699	0.04510641248205702
IMAGE SYNDROME	0.00122699	0.04510641248205702
PSEUDOTRISOMY 13 SYNDROME	0.00122699	0.04510641248205702
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00122699	0.04510641248205702
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00122699	0.04510641248205702
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00122699	0.04510641248205702
KYPHOMELIC DYSPLASIA	0.00122699	0.04510641248205702
INTESTINAL BOTULISM	0.00122699	0.04510641248205702
THAKKER-DONNAI SYNDROME	0.00122699	0.04510641248205702
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00122699	0.04510641248205702
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00122699	0.04510641248205702
TETRASOMY 12P	0.00122699	0.04510641248205702
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00122699	0.04510641248205702
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00122699	0.04510641248205702
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.04510641248205702
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.00122699	0.04510641248205702
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.04510641248205702
TRISOMY 4P	0.00122699	0.04510641248205702
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.04510641248205702
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.04510641248205702
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.04510641248205702
PEARSON SYNDROME	0.00122699	0.04510641248205702
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00122699	0.04510641248205702
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.04510641248205702
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.04510641248205702
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00122699	0.04510641248205702
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00122699	0.04510641248205702
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.04510641248205702
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.04510641248205702
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00122699	0.04510641248205702
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00122699	0.04510641248205702
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00122699	0.04510641248205702
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.04510641248205702
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00122699	0.04510641248205702
MARSHALL-SMITH SYNDROME; MRSHSS	0.00122699	0.04510641248205702
WARBURG MICRO SYNDROME 1	0.00122699	0.04510641248205702
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04510641248205702
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00122699	0.04510641248205702
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00122699	0.04510641248205702
PORPHYRIA, ACUTE HEPATIC	0.00122699	0.04510641248205702
NEMALINE MYOPATHY 7; NEM7	0.00122699	0.04510641248205702
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00122699	0.04510641248205702
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.04510641248205702
MACS SYNDROME	0.00122699	0.04510641248205702
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00122699	0.04510641248205702
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.04510641248205702
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00122699	0.04510641248205702
HAWKINSINURIA	0.00122699	0.04510641248205702
FAMILIAL LAMBDOID SYNOSTOSIS	0.00122699	0.04510641248205702
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.04510641248205702
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00122699	0.04510641248205702
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.04510641248205702
MATTHEW-WOOD SYNDROME	0.00122699	0.04510641248205702
LAURIN-SANDROW SYNDROME	0.00122699	0.04510641248205702
JOHANSON-BLIZZARD SYNDROME	0.00122699	0.04510641248205702
JUNG SYNDROME	0.00122699	0.04510641248205702
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.04510641248205702
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00122699	0.04510641248205702
ISOTRETINOIN SYNDROME	0.00122699	0.04510641248205702
GRANT SYNDROME	0.00122699	0.04510641248205702
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00122699	0.04510641248205702
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00122699	0.04510641248205702
PIERSON SYNDROME	0.00122699	0.04510641248205702
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00122699	0.04510641248205702
STEINERT MYOTONIC DYSTROPHY	0.00122699	0.04510641248205702
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.039959129654568465
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.039959129654568465
WAISMAN SYNDROME; WSMN	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.039959129654568465
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.039959129654568465
SCHIZENCEPHALY	0.001086973	0.039959129654568465
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.039959129654568465
MOSAIC TRISOMY 14	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.039959129654568465
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.039959129654568465
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.039959129654568465
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.039959129654568465
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.039959129654568465
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.039959129654568465
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.039959129654568465
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.039959129654568465
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.039959129654568465
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.039959129654568465
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.039959129654568465
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.039959129654568465
RUVALCABA SYNDROME	0.001086973	0.039959129654568465
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.039959129654568465
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.039959129654568465
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.039959129654568465
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.039959129654568465
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.039959129654568465
L1 SYNDROME	0.001086973	0.039959129654568465
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.039959129654568465
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.039959129654568465
DIGEORGE SYNDROME; DGS	0.001086973	0.039959129654568465
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.039959129654568465
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.039959129654568465
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.039959129654568465
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.039959129654568465
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.039959129654568465
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.039959129654568465
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.039959129654568465
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.039959129654568465
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.039959129654568465
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.039959129654568465
DISTAL MONOSOMY 15Q	0.001086973	0.039959129654568465
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.039959129654568465
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.039959129654568465
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.039959129654568465
KEUTEL SYNDROME	0.001086973	0.039959129654568465
ARGININEMIA	0.001086973	0.039959129654568465
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.039959129654568465
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.039959129654568465
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.039959129654568465
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.039959129654568465
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.039959129654568465
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.039959129654568465
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.039959129654568465
TARP SYNDROME	0.001086973	0.039959129654568465
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.039959129654568465
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.039959129654568465
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.039959129654568465
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.039959129654568465
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.039959129654568465
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.039959129654568465
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.039959129654568465
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.039959129654568465
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.039959129654568465
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.039959129654568465
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.039959129654568465
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.039959129654568465
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.039959129654568465
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.039959129654568465
NETHERTON SYNDROME	0.001086973	0.039959129654568465
WYBURN-MASON SYNDROME	0.001086973	0.039959129654568465
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.039959129654568465
CRANIOPHARYNGIOMA	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.039959129654568465
DUANE RETRACTION SYNDROME	0.001086973	0.039959129654568465
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.039959129654568465
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.039959129654568465
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.039959129654568465
TIMOTHY SYNDROME; TS	0.001086973	0.039959129654568465
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.039959129654568465
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.039959129654568465
ALG1-CDG	0.001086973	0.039959129654568465
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.039959129654568465
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.039959129654568465
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.039959129654568465
CLASSIC PHENYLKETONURIA	0.001086973	0.039959129654568465
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.039959129654568465
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.039959129654568465
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.039959129654568465
MUENKE SYNDROME	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.039959129654568465
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.039959129654568465
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.039959129654568465
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.039959129654568465
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.039959129654568465
HOLOPROSENCEPHALY 7	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.039959129654568465
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.039959129654568465
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.039959129654568465
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.039959129654568465
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.039959129654568465
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.039959129654568465
MACDERMOT-WINTER SYNDROME	0.001086973	0.039959129654568465
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.039959129654568465
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.039959129654568465
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.039959129654568465
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.039959129654568465
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.039959129654568465
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.039959129654568465
LANDAU-KLEFFNER SYNDROME	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.039959129654568465
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.039959129654568465
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.039959129654568465
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.039959129654568465
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.039959129654568465
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.039959129654568465
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.039959129654568465
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.039959129654568465
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.039959129654568465
MIRAGE SYNDROME; MIRAGE	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.039959129654568465
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.039959129654568465
LISSENCEPHALY 4	0.001086973	0.039959129654568465
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.039959129654568465
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.039959129654568465
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.039959129654568465
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.039959129654568465
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.039959129654568465
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.039959129654568465
RECOMBINANT 8 SYNDROME	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.039959129654568465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.039959129654568465
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.039959129654568465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001086973	0.039959129654568465
DONNAI-BARROW SYNDROME	0.001086973	0.039959129654568465
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.039959129654568465
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.039959129654568465
PALLISTER-HALL SYNDROME	0.001086973	0.039959129654568465
KBG SYNDROME	0.001086973	0.039959129654568465
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.039959129654568465
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.039959129654568465
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.039959129654568465
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.039959129654568465
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.039959129654568465
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.039959129654568465
15Q14 MICRODELETION SYNDROME	0.001086973	0.039959129654568465
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.039959129654568465
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.039959129654568465
ISOVALERIC ACIDEMIA	0.001086973	0.039959129654568465
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.039959129654568465
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.039959129654568465
OPTIC PATHWAY GLIOMA	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.039959129654568465
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.039959129654568465
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.039959129654568465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.039959129654568465
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.039959129654568465
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.039959129654568465
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.039959129654568465
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.039959129654568465
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.039959129654568465
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.039959129654568465
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.039959129654568465
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.039959129654568465
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.039959129654568465
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.039959129654568465
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.039959129654568465
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.039959129654568465
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.039959129654568465
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.039959129654568465
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.039959129654568465
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.039959129654568465
MUCOPOLYSACCHARIDOSIS TYPE 2	0.001086973	0.039959129654568465
PHACE ASSOCIATION	0.001086973	0.039959129654568465
PFEIFFER SYNDROME TYPE 2	0.001086973	0.039959129654568465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.039959129654568465
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.039959129654568465
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.039959129654568465
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.039959129654568465
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.039959129654568465
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.039959129654568465
HYDRANENCEPHALY	0.001086973	0.039959129654568465
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.039959129654568465
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.039959129654568465
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.039959129654568465
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.039959129654568465
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.039959129654568465
JOUBERT SYNDROME 26	0.000545554	0.020055569935562744
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020055569935562744
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020055569935562744
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020055569935562744
SEPTOOPTIC DYSPLASIA	0.000545554	0.020055569935562744
MIETENS SYNDROME	0.000545554	0.020055569935562744
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020055569935562744
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020055569935562744
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020055569935562744
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020055569935562744
TRANSALDOLASE DEFICIENCY	0.000545554	0.020055569935562744
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020055569935562744
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020055569935562744
BARDET-BIEDL SYNDROME 2	0.000545554	0.020055569935562744
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020055569935562744
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020055569935562744
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020055569935562744
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020055569935562744
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020055569935562744
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020055569935562744
NOONAN SYNDROME 11; NS11	0.000545554	0.020055569935562744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.020055569935562744
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.020055569935562744
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020055569935562744
RABSON-MENDENHALL SYNDROME	0.000545554	0.020055569935562744
RAHMAN SYNDROME	0.000545554	0.020055569935562744
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020055569935562744
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020055569935562744
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020055569935562744
WOLMAN DISEASE	0.000545554	0.020055569935562744
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020055569935562744
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020055569935562744
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020055569935562744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020055569935562744
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020055569935562744
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020055569935562744
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020055569935562744
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020055569935562744
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020055569935562744
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020055569935562744
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020055569935562744
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020055569935562744
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020055569935562744
ALAZAMI-YUAN SYNDROME	0.000545554	0.020055569935562744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020055569935562744
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020055569935562744
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020055569935562744
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020055569935562744
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020055569935562744
CULLER-JONES SYNDROME; CJS	0.000545554	0.020055569935562744
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020055569935562744
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020055569935562744
XIA-GIBBS SYNDROME	0.000545554	0.020055569935562744
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562744
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020055569935562744
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020055569935562744
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020055569935562744
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020055569935562744
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020055569935562744
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020055569935562744
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020055569935562744
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020055569935562744
OKAMOTO SYNDROME	0.000545554	0.020055569935562744
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020055569935562744
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020055569935562744
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020055569935562744
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020055569935562744
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020055569935562744
NOONAN SYNDROME 2; NS2	0.000545554	0.020055569935562744
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020055569935562744
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020055569935562744
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020055569935562744
MOSAIC TRISOMY 9	0.000545554	0.020055569935562744
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020055569935562744
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020055569935562744
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020055569935562744
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020055569935562744
TRISOMY 9P	0.000545554	0.020055569935562744
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020055569935562744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020055569935562744
NOONAN SYNDROME 9; NS9	0.000545554	0.020055569935562744
AL-RAQAD SYNDROME; ARS	0.000545554	0.020055569935562744
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020055569935562744
FRIAS SYNDROME	0.000545554	0.020055569935562744
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020055569935562744
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020055569935562744
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020055569935562744
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020055569935562744
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020055569935562744
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020055569935562744
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020055569935562744
BRESEK SYNDROME	0.000545554	0.020055569935562744
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020055569935562744
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020055569935562744
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020055569935562744
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020055569935562744
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020055569935562744
HURLER SYNDROME	0.000545554	0.020055569935562744
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020055569935562744
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020055569935562744
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020055569935562744
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020055569935562744
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020055569935562744
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020055569935562744
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020055569935562744
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020055569935562744
EVEN-PLUS SYNDROME	0.000545554	0.020055569935562744
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020055569935562744
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020055569935562744
SYNDROMIC DIARRHEA	0.000545554	0.020055569935562744
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020055569935562744
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020055569935562744
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020055569935562744
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020055569935562744
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020055569935562744
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020055569935562744
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020055569935562744
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020055569935562744
LIG4 SYNDROME	0.000545554	0.020055569935562744
CHOPS SYNDROME; CHOPS	0.000545554	0.020055569935562744
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020055569935562744
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020055569935562744
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020055569935562744
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020055569935562744
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020055569935562744
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020055569935562744
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020055569935562744
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020055569935562744
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020055569935562744
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020055569935562744
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020055569935562744
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020055569935562744
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562744
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020055569935562744
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020055569935562744
TREACHER-COLLINS SYNDROME	0.000545554	0.020055569935562744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020055569935562744
MEIER-GORLIN SYNDROME 7	0.000545554	0.020055569935562744
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020055569935562744
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020055569935562744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020055569935562744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020055569935562744
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020055569935562744
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020055569935562744
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020055569935562744
HYDROXYKYNURENINURIA	0.000545554	0.020055569935562744
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020055569935562744
CDAGS SYNDROME	0.000545554	0.020055569935562744
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020055569935562744
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020055569935562744
AUSTRALIA ANTIGEN	0.000545554	0.020055569935562744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020055569935562744
CHAR SYNDROME	0.000545554	0.020055569935562744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020055569935562744
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020055569935562744
OGDEN SYNDROME	0.000545554	0.020055569935562744
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020055569935562744
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020055569935562744
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020055569935562744
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020055569935562744
ZEBRA BODY MYOPATHY	0.000545554	0.020055569935562744
RIGID SPINE SYNDROME	0.000545554	0.020055569935562744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020055569935562744
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020055569935562744
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020055569935562744
FARBER DISEASE	0.000545554	0.020055569935562744
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020055569935562744
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020055569935562744
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020055569935562744
ROBERTS SYNDROME	0.000545554	0.020055569935562744
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020055569935562744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020055569935562744
ABETAL34V AMYLOIDOSIS	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020055569935562744
CHAR SYNDROME	0.000545554	0.020055569935562744
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020055569935562744
SAY-BARBER-MILLER SYNDROME	0.000545554	0.020055569935562744
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020055569935562744
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020055569935562744
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020055569935562744
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020055569935562744
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020055569935562744
HOLOPROSENCEPHALY 11	0.000545554	0.020055569935562744
STEEL SYNDROME; STLS	0.000545554	0.020055569935562744
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562744
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562744
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020055569935562744
ZECHI-CEIDE SYNDROME	0.000545554	0.020055569935562744
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.020055569935562744
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020055569935562744
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020055569935562744
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020055569935562744
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020055569935562744
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020055569935562744
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020055569935562744
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020055569935562744
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020055569935562744
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020055569935562744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020055569935562744
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020055569935562744
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020055569935562744
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020055569935562744
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020055569935562744
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020055569935562744
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020055569935562744
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.020055569935562744
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020055569935562744
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020055569935562744
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020055569935562744
JAWAD SYNDROME	0.000545554	0.020055569935562744
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020055569935562744
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020055569935562744
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020055569935562744
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020055569935562744
HYPERTRICHOSIS CUBITI	0.000545554	0.020055569935562744
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020055569935562744
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020055569935562744
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020055569935562744
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020055569935562744
TEMTAMY SYNDROME	0.000545554	0.020055569935562744
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020055569935562744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020055569935562744
DYSKERATOSIS CONGENITA	0.000545554	0.020055569935562744
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020055569935562744
DEXTROCARDIA	0.000545554	0.020055569935562744
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020055569935562744
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020055569935562744
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020055569935562744
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.020055569935562744
TRISOMY 8Q	0.000545554	0.020055569935562744
DISTAL TRISOMY 6P	0.000545554	0.020055569935562744
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020055569935562744
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020055569935562744
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020055569935562744
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020055569935562744
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020055569935562744
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020055569935562744
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020055569935562744
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020055569935562744
TARP SYNDROME; TARPS	0.000545554	0.020055569935562744
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020055569935562744
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020055569935562744
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020055569935562744
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020055569935562744
OROTIC ACIDURIA	0.000545554	0.020055569935562744
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020055569935562744
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020055569935562744
RAINE SYNDROME	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020055569935562744
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020055569935562744
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020055569935562744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020055569935562744
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020055569935562744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020055569935562744
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020055569935562744
CINCA SYNDROME	0.000545554	0.020055569935562744
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020055569935562744
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020055569935562744
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020055569935562744
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.020055569935562744
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020055569935562744
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020055569935562744
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020055569935562744
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020055569935562744
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.020055569935562744
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020055569935562744
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020055569935562744
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020055569935562744
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020055569935562744
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020055569935562744
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020055569935562744
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.020055569935562744
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020055569935562744
EPIDERMAL NEVUS SYNDROME	0.000545554	0.020055569935562744
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020055569935562744
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020055569935562744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020055569935562744
ISOLATED PLAGIOCEPHALY	0.000545554	0.020055569935562744
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020055569935562744
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020055569935562744
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020055569935562744
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020055569935562744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020055569935562744
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020055569935562744
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020055569935562744
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020055569935562744
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020055569935562744
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020055569935562744
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020055569935562744
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020055569935562744
ATELOSTEOGENESIS TYPE III	0.000545554	0.020055569935562744
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020055569935562744
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020055569935562744
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020055569935562744
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020055569935562744
LOWRY-MACLEAN SYNDROME	0.000545554	0.020055569935562744
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020055569935562744
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.01990355971900572
SUBEPENDYMOMA	0.000541419	0.01990355971900572
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.01990355971900572
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.01990355971900572
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.01990355971900572
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.01990355971900572
EPENDYMOMA	0.000541419	0.01990355971900572
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01990355971900572
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.01990355971900572
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.01990355971900572
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.01990355971900572
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.01990355971900572
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.01990355971900572
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.01990355971900572
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.01990355971900572
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.01990355971900572
EBOLA HEMORRHAGIC FEVER	0.000541419	0.01990355971900572
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.01990355971900572
WORSTER-DROUGHT SYNDROME	0.000541419	0.01990355971900572
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.01990355971900572
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.01990355971900572
PARTINGTON SYNDROME	0.000541419	0.01990355971900572
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.01990355971900572
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.01990355971900572
RIFT VALLEY FEVER	0.000541419	0.01990355971900572
THREONINEMIA	0.000541419	0.01990355971900572
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.01990355971900572
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.01990355971900572
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.01990355971900572
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.01990355971900572
DERMOTRICHIC SYNDROME	0.000541419	0.01990355971900572
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.01990355971900572
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.01990355971900572
IMMUNODEFICIENCY 47	0.000541419	0.01990355971900572
PSEUDO-TORCH SYNDROME 2	0.000541419	0.01990355971900572
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.01990355971900572
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.01990355971900572
FILIPPI SYNDROME; FLPIS	0.000541419	0.01990355971900572
PARIETAL FORAMINA	0.000541419	0.01990355971900572
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.01990355971900572
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.01990355971900572
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.01990355971900572
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.01990355971900572
CONGENITAL HYDROCEPHALUS	0.000541419	0.01990355971900572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.01990355971900572
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.01990355971900572
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.01990355971900572
INCONTINENTIA PIGMENTI; IP	0.000541419	0.01990355971900572
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.01990355971900572
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.01990355971900572
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.01990355971900572
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.01990355971900572
ASPARTYLGLUCOSAMINURIA	0.000541419	0.01990355971900572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.01990355971900572
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.01990355971900572
TAY-SACHS DISEASE; TSD	0.000541419	0.01990355971900572
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.01990355971900572
CENTRAL DIABETES INSIPIDUS	0.000541419	0.01990355971900572
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.01990355971900572
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.01990355971900572
STURGE-WEBER SYNDROME	0.000541419	0.01990355971900572
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.01990355971900572
NIPAH VIRUS DISEASE	0.000541419	0.01990355971900572
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.01990355971900572
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.01990355971900572
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.01990355971900572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.01990355971900572
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.01990355971900572
PFEIFFER SYNDROME TYPE 3	0.000541419	0.01990355971900572
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.01990355971900572
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.01990355971900572
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.01990355971900572
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.01990355971900572
DARIER-WHITE DISEASE; DAR	0.000541419	0.01990355971900572
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.01990355971900572
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.01990355971900572
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.01990355971900572
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.01990355971900572
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.01990355971900572
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.01990355971900572
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.01990355971900572
CROUZON SYNDROME	0.000541419	0.01990355971900572
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.01990355971900572
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.01990355971900572
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.01990355971900572
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.01990355971900572
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.01990355971900572
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.01990355971900572
MERCURY POISONING	0.000541419	0.01990355971900572
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.01990355971900572
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.01990355971900572
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.01990355971900572
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.01990355971900572
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.01990355971900572
MOYNAHAN SYNDROME	0.000541419	0.01990355971900572
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.01990355971900572
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.01990355971900572
GLIOBLASTOMA	0.000541419	0.01990355971900572
TAKAYASU ARTERITIS	0.000541419	0.01990355971900572
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.01990355971900572
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.01990355971900572
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.01990355971900572
ADAMS-OLIVER SYNDROME	0.000541419	0.01990355971900572
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.01990355971900572
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.01990355971900572
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.01990355971900572
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.01990355971900572
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.01990355971900572
ALZHEIMER DISEASE 3; AD	0.000541419	0.01990355971900572
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.01990355971900572
INSULINOMA	0.000541419	0.01990355971900572
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.01990355971900572
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.01990355971900572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.01990355971900572
HYPERPROLINEMIA TYPE 1	0.000541419	0.01990355971900572
PAPILLORENAL SYNDROME	0.000541419	0.01990355971900572
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.01990355971900572
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.01990355971900572
GALACTOSIALIDOSIS	0.000541419	0.01990355971900572
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.01990355971900572
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.01990355971900572
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.01990355971900572
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.01990355971900572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.01990355971900572
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.01990355971900572
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.01990355971900572
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.01990355971900572
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.01990355971900572
MOYAMOYA DISEASE	0.000541419	0.01990355971900572
EPILEPSY, READING	0.000541419	0.01990355971900572
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.01990355971900572
PINEOBLASTOMA	0.000541419	0.01990355971900572
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.01990355971900572
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.01990355971900572
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.01990355971900572
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.01990355971900572
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.01990355971900572
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.01990355971900572
PERRAULT SYNDROME 3	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.01990355971900572
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.01990355971900572
CYSTATHIONINURIA	0.000541419	0.01990355971900572
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.01990355971900572
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.01990355971900572
MICROSPORIDIOSIS	0.000541419	0.01990355971900572
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.01990355971900572
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.01990355971900572
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.01990355971900572
FRONTAL ENCEPHALOCELE	0.000541419	0.01990355971900572
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.01990355971900572
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.01990355971900572
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.01990355971900572
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.01990355971900572
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.01990355971900572
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.01990355971900572
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.01990355971900572
KLEEFSTRA SYNDROME	0.000541419	0.01990355971900572
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.01990355971900572
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.01990355971900572
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.01990355971900572
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.01990355971900572
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.01990355971900572
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.01990355971900572
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.01990355971900572
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.01990355971900572
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.01990355971900572
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.01990355971900572
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.01990355971900572
PROTEUS SYNDROME	0.000541419	0.01990355971900572
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.01990355971900572
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.01990355971900572
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.01990355971900572
RABIES	0.000541419	0.01990355971900572
CADASIL	0.000541419	0.01990355971900572
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.01990355971900572
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.01990355971900572
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.01990355971900572
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.01990355971900572
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.01990355971900572
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.01990355971900572
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.01990355971900572
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.01990355971900572
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.01990355971900572
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.01990355971900572
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.01990355971900572
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.01990355971900572
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.01990355971900572
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.01990355971900572
ATYPICAL RETT SYNDROME	0.000541419	0.01990355971900572
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.01990355971900572
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.01990355971900572
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01990355971900572
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.01990355971900572
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.01990355971900572
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.01990355971900572
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.01990355971900572
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.01990355971900572
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.01990355971900572
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.01990355971900572
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.01990355971900572
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.01990355971900572
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.01990355971900572
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.01990355971900572
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.01990355971900572
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.01990355971900572
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.01990355971900572
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.01990355971900572
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.01990355971900572
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.01990355971900572
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.01990355971900572
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.01990355971900572
KIFAFA SEIZURE DISORDER	0.000541419	0.01990355971900572
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.01990355971900572
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.01990355971900572
SECKEL SYNDROME 1; SCKL1	0.000541419	0.01990355971900572
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.01990355971900572
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.01990355971900572
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.01990355971900572
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.01990355971900572
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.01990355971900572
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.01990355971900572
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.01990355971900572
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.01990355971900572
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.01990355971900572
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.01990355971900572
PROLACTINOMA	0.000541419	0.01990355971900572
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.01990355971900572
FOUNTAIN SYNDROME	0.000541419	0.01990355971900572
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.01990355971900572
SANJAD-SAKATI SYNDROME	0.000541419	0.01990355971900572
BETA-MANNOSIDOSIS	0.000541419	0.01990355971900572
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.01990355971900572
GURRIERI SYNDROME	0.000541419	0.01990355971900572
BERNARD-SOULIER SYNDROME	0.000541419	0.01990355971900572
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.01990355971900572
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.01990355971900572
PORENCEPHALY	0.000541419	0.01990355971900572
FRYNS SYNDROME; FRNS	0.000541419	0.01990355971900572
MYASTHENIA GRAVIS	0.000541419	0.01990355971900572
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.01990355971900572
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.01990355971900572
LIPOID PROTEINOSIS	0.000541419	0.01990355971900572
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.01990355971900572
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.01990355971900572
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.01990355971900572
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.01990355971900572
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.01990355971900572
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.01990355971900572
ISOLATED BILIARY ATRESIA	0.000541419	0.01990355971900572
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.01990355971900572
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.01990355971900572
RAMON SYNDROME	0.000541419	0.01990355971900572
HYPERPROLINEMIA, TYPE II	0.000541419	0.01990355971900572
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.01990355971900572
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.01990355971900572
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.01990355971900572
NEVUS COMEDONICUS SYNDROME	0.000541419	0.01990355971900572
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.01990355971900572
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.01990355971900572
HYPER-BETA-ALANINEMIA	0.000541419	0.01990355971900572
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.01990355971900572
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.01990355971900572
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.01990355971900572
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.01990355971900572
DYSOSTEOSCLEROSIS	0.000541419	0.01990355971900572
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.01990355971900572
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.01990355971900572
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.01990355971900572
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.01990355971900572
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.01990355971900572
LUJO HEMORRHAGIC FEVER	0.000541419	0.01990355971900572
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.01990355971900572
AICA-RIBOSIDURIA	0.000541419	0.01990355971900572
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.01990355971900572
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.01990355971900572
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.01990355971900572
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.01990355971900572
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.01990355971900572
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.01990355971900572
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.01990355971900572
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.01990355971900572
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.01990355971900572
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01990355971900572
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.01990355971900572
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.01990355971900572
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.01990355971900572
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.01990355971900572
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.01990355971900572
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.01990355971900572
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.01990355971900572
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.01990355971900572
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.01990355971900572
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.01990355971900572
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.01990355971900572
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.01990355971900572
PHENYLKETONURIA	0.000541419	0.01990355971900572
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.01990355971900572
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.01990355971900572
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.01990355971900572
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.01990355971900572
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.01990355971900572
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.01990355971900572
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.01990355971900572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.01990355971900572
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.01990355971900572
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.01990355971900572
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.01990355971900572
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.01990355971900572
SNEDDON SYNDROME	0.000541419	0.01990355971900572
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.01990355971900572
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.01990355971900572
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.01990355971900572
STURGE-WEBER SYNDROME	0.000541419	0.01990355971900572
RAMON SYNDROME	0.000541419	0.01990355971900572
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.01990355971900572
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.01990355971900572
CRANIOSYNOSTOSIS 2	0.000541419	0.01990355971900572
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.01990355971900572
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.01990355971900572
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.01990355971900572
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.01990355971900572
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.01990355971900572
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.01990355971900572
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.01990355971900572
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.01990355971900572
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01990355971900572
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.01990355971900572
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.01990355971900572
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.01990355971900572
CRYPTOCOCCOSIS	0.000541419	0.01990355971900572
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.01990355971900572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.01990355971900572
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.01990355971900572
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.01990355971900572
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.01990355971900572
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.01990355971900572
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.01990355971900572
NOCARDIOSIS	0.000541419	0.01990355971900572
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.01990355971900572
MOGS-CDG	0.000541419	0.01990355971900572
20P13 MICRODELETION SYNDROME	0.000541419	0.01990355971900572
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.01990355971900572
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.01990355971900572
ALG2-CDG	0.000541419	0.01990355971900572
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.01990355971900572
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.01990355971900572
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.01990355971900572
AUTISM	0.000541419	0.01990355971900572
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.01990355971900572
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.01990355971900572
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.01990355971900572
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.01990355971900572
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.01990355971900572
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.01990355971900572
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.01990355971900572
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.01990355971900572
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.01990355971900572
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.01990355971900572
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.01990355971900572
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.01990355971900572
ROSAÏ-DORFMAN DISEASE	0.000541419	0.01990355971900572
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.01990355971900572
NASU-HAKOLA DISEASE	0.000541419	0.01990355971900572
ENCEPHALITIS LETHARGICA	0.000541419	0.01990355971900572
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.01990355971900572
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.01990355971900572
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.01990355971900572
SCRUB TYPHUS	0.000541419	0.01990355971900572
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.01990355971900572
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.01990355971900572
COWDEN SYNDROME 5; CWS5	0.000541419	0.01990355971900572
SNEDDON SYNDROME	0.000541419	0.01990355971900572
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.01990355971900572
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.01990355971900572
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.01990355971900572
COWDEN SYNDROME 6; CWS6	0.000541419	0.01990355971900572
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.01990355971900572
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.01990355971900572
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.01990355971900572
47,XYY SYNDROME	0.000541419	0.01990355971900572
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.01990355971900572
